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The Chemistry-Information-Computer (CIC) division [1] of the German 
Chemical Society (Gesellschaft Deutscher Chemiker e.V.) hosted the 11th 
German Conference on Chemoinformatics (GCC2015) from the 8th to the 
10th of November 2015 in Fulda, Germany [2]. The conference reflected 
the new role of chemoinformatics in the modern information world. Dis-
cussed topics were related to the utilization of computers in chemistry, 
pharmacy, material sciences and biology. The Program Committee took 
great care to compile a scientific program which covers a wide range of 
subjects: from chemo- and bioinformatics to molecular modelling, from 
fundamental academic research to industrial applications.
The plenary sessions, which comprised a total of 28 oral presentations, 
started off with a newly introduced session Sunday Highlights char-
acterized by three keynotes from high-profile speakers. Subsequent 
sessions were a mix of invited keynote speakers and selected contri-
butions submitted by the community. The session Research Telegrams 
was exclusively dedicated to the presentation of the current status 
of PhD students’ work. In addition, 61 poster contributions were pre-
sented in two poster sessions. The more than 135 attendees from 12 
nations proofed that the German Conference on Chemoinformatics is 
a well-established event in the international Chemoinformatics and 
Modelling community (Fig. 1).
The CIC-Award for Computational Chemistry honors outstanding 
doctoral dissertations and master thesis in the fields of the scientific 
specialties of the Chemistry-Information-Computer division. In 2014, 
the German Conference on Chemoinformatics was jointly held with 
the International Conference on Chemical Structures (ICCS) [3], which 
led to the awarding of the CIC-Award for Computational Chemistry for 
both the year 2014 and the year 2015 at the GCC2015. The CIC-Award 
for Computational Chemistry for the best dissertation thesis for 2014 
was granted to Achim Sandmann, who worked on his dissertation the-
sis under the supervision of Dr. Harald Lahnig at the Friedrich-Alexan-
der-Universität Erlangen-Nürnberg. Both Patrick Kibies, supervised by 
Prof. Dr. Stefan Kast from the TU Dortmund, and Manuel Ruff, super-
vised by Prof. Dr. Frank Böckler from the Eberhard Karls University 
Tübingen, were granted the CIC-Award for Computational Chemistry 
for their outstanding master theses. Among the six oral contributions 
presented in the plenary session Research Telegrams the work of 
Markus Zimmermann titled “ChemPLPXB: Implementation of QM-
based terms for the recognition of halogen bonding in drug design” 
was selected as the best dissertation thesis 2015. Markus Zimmer-
mann prepared his dissertation thesis under the supervision of Prof. 
Dr. Frank Böckler at the Eberhard Karls University Tübingen (Fig. 2).
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Fig. 1 Participants of the 11th German Conference on Chemoinfor‑
matics (GCC2015), November 8–10, 2015 in Fulda, Germany
Fig. 2 The awardees of the CIC Poster Award 2015 and the CIC‑
Award for Computational Chemistry 2014 and 2015: from left to right, 
Christiane Ehrt (poster award, TU Dortmund University, Germany), 
Tobias Brinkjost (poster award, TU Dortmund, Germany), Stefan Bietz 
(poster award, Universität Hamburg, Germany), Patrick J. Kibies (CIC‑
Award for Computational Chemistry, master thesis, TU Dortmund, 
Germany), Dr. Achim Sandmann (CIC‑Award for Computational 
Chemistry, dissertation thesis, Friedrich‑Alexander‑Universität 
Erlangen‑Nürnberg, Germany), Manuel Ruff (CIC‑Award for Compu‑
tational Chemistry, master thesis, Eberhard Karls University Tübingen, 
Germany), Markus O. Zimmermann (CIC‑Award for Computational 
Chemistry, dissertation thesis, Eberhard Karls University Tübingen, 
Germany) and Thomas Engel (Chair of the GDCh CIC division)
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This presentation will describe how structural biology, molecular 
pharmacology, and medicinal chemistry studies can be combined 
with molecular modeling and chemoinformatics analyses for a 
more accurate description and prediction of structural determi-
nants of protein-ligand binding, functional activity, and selectivity. 
The challenges and possibilities of structural chemogenomics stud-
ies will be discussed, including the integration of large volumes of 
heterogeneous pharmacological and chemical data for different 
protein targets and the development of structure-based virtual 
screening and computer-aided drug design approaches to discover 
novel small molecule ligands with well defined functional activity 
and protein selectivity profiles. The potential of molecular dynam-
ics simulation methods to complement hybrid structural biology 
studies will be demonstrated for the investigation the mechanisms 
of conformational selection and protein-ligand binding kinet-
ics. In the final part of the presentation structural protein-ligand 
interaction databases will be described that link structure-based 
protein-ligand interaction maps to protein ligand topology and can 
be used as structural chemogenomics tools to navigate medicinal 
chemistry space.
Acknowledgments: The Netherlands eScience Center (NLeSC)/Neth-
erlands Organisation for Scientific Research (NWO) (Enabling Tech-
nologies project: 3D-e-Chem) [027.014.201], EU/EFPIA Innovative 
Medicines Initiative Joint Undertaking, K4DD grant no 115366, COST 
Action CM1207 (GLISTEN).
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Children who misbehave are often punished by being made to imple-
ment simulated annealing on top of a Monte Carlo scheme. Students 
who cannot afford a Gucci handbag strive to be fashionable by pro-
gramming up a genetic algorithm. Computer scientists often take 
problems from chemistry, beat them until their bones have turned to 
jelly and squash them into a form suitable for a dynamic programming 
method.
The question is, whether these approaches are really the best for 
problems like docking or RNA folding, where you may want optimal 
solutions or a sampling of likely solutions. If your problem has gra-
dient information or a well-defined statistical distribution, maybe 
you should use them with pride in your voice and a bounce in your 
step.
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More than 20 years after their first climax in the 80s and 90s, therapeu-
tic peptides and proteins are currently experiencing a renaissance as 
drug molecules as it is believed that they offer key advantages over tra-
ditional small molecules, such as fewer toxic side effects. Identification 
of compounds for clinical development still requires multiparameter 
optimization as these modalities may suffer from potential liabilities 
such as chemical stability, solubility and aggregation propensity.
In this talk some of the work in the area of structure-activity and 
structure-property modelling and its application in the design of new 
peptides and proteins will be highlighted. Traditionally, many compu-
tational prediction tools that have been reported in the literature are 
purely based on sequence-based descriptors. Our strategy bridges the 
worlds of bioinformatics and chemoinformatics by using approaches 
that are based on 3D structures of individual amino acids as well as on 
the full 3D structure of peptides or proteins.
Here, the applicability of such methods to unnatural or modified 
amino acids is of particular importance as introducing those into the 
peptide sequence might significantly impact biophysical peptide 
properties. While the Z-scale descriptors introduced originally by Wold 
[1] are based on experimental values, we have applied computational 
amino acid descriptors [2] derived using the CoMFA method [3] for 
building QSAR models, which are amenable to general amino acids. 
Details will be shown on how the descriptors are derived as well as 
approaches for the analysis and interpretation of the resulting models.
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With the advent of the Human Genome Project came the industriali-
sation of the drug discovery process and a belief that combinatorial 
chemistry and high throughput screening would deliver molecules 
with increased potency, against a single target of interest. Yet the 
attrition rate is still at the 10% mark and there remain many human 
diseases for which no effective treatment exists. As Swinney et al have 
shown [1], there is compelling evidence that first-in-class drugs are 
more likely to be found by assays that measure a clinically meaning-
ful phenotype in a physiologically relevant system rather than a single 
target based screening approach in an artificial setting.
One perceived issue with phenotypic screening is the lack of mecha-
nistic knowledge. Whilst understanding mechanism of action (MOA) is 
not a prerequisite for FDA approval, it can guide a medicinal chemistry 
effort, predict potential toxicities and help define patient populations 
for clinical trials and ultimately the market place. There are a number 
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of in vitro approaches to target deconvolution. However, these tend 
to be of lower throughput and better placed later in a screening cas-
cade. So there is a real need for in silico based approaches that can be 
deployed early on in a drug discovery programme to identify potential 
MOAs.
Using publicly available data on the Published Kinase Inhibitor Set 
(PKIS) [2,3], we describe the application of Formal Concept Analysis 
(FCA), an association mining technique with roots in set theory, to 
the problem of deconvoluting a phenotypic screen. We describe each 
compound in the PKIS by the set of kinases it inhibits. We then con-
struct a Galois Lattice, whose nodes correspond to a set of compounds 
inhibiting a common set of kinases and where two nodes are con-
nected if the compound set of the child node is a subset of the com-
pound set of the parent node. Lattice nodes enriched with compounds 
that promote neurite outgrowth in rat inform on which kinases should 
be targeted when seeking small molecules that encourage CNS axon 
repair following injury. The targets we identify using this unsuper-
vised and interpretable approach, are in line with those identified 
in [3] where here the authors use a combination of support vector 
machines, considered a black box method, and mutual information, 
then confirm in siRNA studies.
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Chemists pursue the discovery of new chemical reactions to meet 
the demand for transformations that are more efficient, are more 
environmentally benign or allow the synthesis of previously inac-
cessible molecules [1]. Usually, discovery starts with an idea derived 
from knowledge, which is subsequently tested in experiments. The 
outcome of the experiments then increases knowledge, leading to 
a cyclic process. In Cognitive Science, initial hypothesis generation 
is attributed to analogical reasoning, and creativity is described as a 
process of combining seemingly unrelated knowledge [2]. However, 
as published chemical knowledge increases rapidly, many interesting 
hypotheses may never be recognized. Computational approaches for 
the discovery of unprecedented reactions are therefore desirable, but 
only seldom reported and not applicable to modern catalytic reactions 
[3,4]. We have developed a scalable model to obtain hypotheses for 
unprecedented catalytic chemical reactions based on a set of known 
reactions. Given just the starting materials as the input, our model 
proposes hypotheses about the product and the reaction conditions 
by identifying analogies in the reactivity the reactants. In a validation 
study, the model correctly assigns 94% of a reaction set unknown to 
the model as plausible reactions and provides the correct product 
structures. In further studies, we show that our model can infer cor-
rect products and accurate (or highly similar and reasonable) reaction 
conditions incl. catalysts and reagents for recently published reactions.
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Nowadays crime scene investigations and evidence analysis are enor-
mously challenged by the rapidly growing crime. In the last decade 
crime situation has changed dramatically and forensic science must be 
fitted to current challenges (e.g. cybercrime) at its best. Keeping the 
forensics up to date, it is essential to perform research projects for the 
development of new and powerful methods. Over the course of time 
analytical achievements provide additional possibilities for case work 
analysis we could not imagine a couple of years earlier. Forensic science 
must benefit from these efforts in the field of analytics. It needs to be 
proved frequently, how new analytical methods can support forensic 
investigations. So far unsolved problems can be faced by introducing 
new techniques in the forensics considering the applicability in case 
work. It is an important point to always think about how feasible certain 
methods are for case work. Besides the development of new techniques, 
established methods need to be optimized frequently to always obtain 
most reliable results for crime scene investigations. Due to mentioned 
reasons, research and development in general is a big issue in forensics 
and especially for the forensic science institute of the Bundeskriminal-
amt Germany. Some selected research projects will be presented to give 
an overview of potential forensic methods for the future.
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Protein-surface interactions are ubiquitous in the crowded cytosol, 
where proteins encounter a variety of surfaces, ranging from mem-
branes surfaces, to the surfaces presented by chaperone molecules. 
Protein-surface interactions are also at the heart of a number of 
emerging technologies, including protein micro-arrays, biosensors 
and biomaterials. The effect of surfaces on protein structure and sta-
bility can vary substantially depending on the chemical composi-
tion of the surface. In this talk, I will present coarse-grained as well as 
detailed atomistic simulations of the folding of small proteins in the 
presence of surfaces of relevance to biology and biotechnology. Exam-
ples will range from adhesion of intrinsically disordered marine mus-
sel proteins on organic thin films, to globular protein adsorption on 
membrane-mimics.
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A basic challenge for biomolecular simulations is the necessity to study 
comparatively large and complex structures in the order of at least tens 
of nanometers for comparatively long times up to the microseconds 
scale. A mesoscopic coarse-grained approach neglects precise atomic 
interactions but tries to keep essential features of the complex system of 
interest—and thus may be helpful to adequately describe average collab-
orative interactions within large biomolecular ensembles and their effects.
The new mesoscopic approach comprises the Molecular Fragment 
Dynamics (MFD) variant of the established mesoscopic Dissipative Par-
ticle Dynamics (DPD) simulation technique, adequate fragmentation 
schemata for all biomolecular species of interest (e.g., phospholipids, 
amino acids, peptides and proteins), the construction of a versatile 
biomolecular fragment set, Cheminformatics concepts and tools for 
fragment structure representations and handling, concepts for pep-
tide and protein 3D structure treatment like backbone potentials for 
structural rigidity/flexibility and an integrative software architecture 
for practical realization [1]. First simulation results for phospholipid 
membranes, peptides/proteins and their mutual interactions demon-
strate opportunities and limitations [2].
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We investigate the methodological development of coarse grained 
‘mesoscale’ simulations for biomolecular affinity calculations such as 
in ligand-protein interactions, where the ligand is potentially of mac-
romolecular dimension. The ambitious aim is to reach thermodynamic 
accuracy of 1–3 kT in free energy of binding prediction, by including 
all relevant interactions, using soft potentials, thermodynamic integra-
tion and calibration using engineering thermodynamics data. In the 
approach, small groups of 2–3 heteroatoms are combined in a single 
simulation unit. Such bead, typical of the mesoscale nomenclature, is 
to be considered a tiny molecular fragment. Since in drug discovery 
screening of many thousands if not millions of compounds is the rule, 
the all-determining factor for the success of the approach is the fast 
automation of fragmentation and ensuing parameterization (Auto-
mated Fragmentation Parameterization, AFP). We have developed an 
AFP protocol that combines elements from chemical informatics (for 
finding optimal fragments) and engineering thermodynamics (for 
parameterization through surface charge interactions). The first results 
look promising. We have calculated fragments for ~100k molecules 
(PUBCHEM data base) by rule based simulated annealing. Classifica-
tion of fragments shows a distribution with a typical Zipf regression. 
We estimate that five to ten thousand unique fragments are enough 
to cover all organic molecules in the CAS database. As for the param-
eterization: we rely heavily on non-biological engineering thermody-
namics data, such as Vapor-Liquid Equlibrium diagrams from the NIST 
database (Thermodynamics Data Engine). This unique set of data that 
covers excess Gibbs energies for a wide range of binary fluid systems, 
and is an ultimate test for any simulation that aims to produce results 
of thermodynamic accuracy. So far, this data has been the bread and 
butter of ultrafast and accurate equation based engineering thermo-
dynamics models, such as UNIFAC or COSMO-RS. Simulation methods 
up till now have been to slow and inaccurate for massive validation. 
Here our mesoscale simulation approach reaches an accuracy of a 
fraction of a kT per fragment (1–3 kT per molecule), this is on par, or 
better than the engineering methods, with the enormous advantage 
that our approach is intrinsically 3-dimensional. All is still within very 
reasonable calculation times on modest computational resources. 
We complement the presentation with results on logP prediction and 
lignine, keratine and kinase modelling. The software development is 
sponsored by CULGI, a large consortium from oil, personal care and 
chemical industries.
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Solvation plays an essential role for all kinds of physiologically relevant 
systems and phenomena. Not only water as the key solvent for life but 
also electrolytes and osmo-lytes modulate molecular interactions with 
implications for structure, dynamics, and thermodynamics. Computa-
tional modeling of (bio-)molecular systems in solution re-quires taking 
into account the much larger number of solvent particles in compari-
son with solute species. This results in vast technical effort, e.g., to treat 
molecular dynam-ics by atomistic simulations in full detail although 
most of the explicitly considered sol-vent molecules have only statisti-
cal influence on biological function due to the sepa-ration of dynami-
cal time scales of solute and solvent.
An efficient way to account for solvent-mediated effects in atomistic 
simulations is to treat the solvent statistically, either by structureless 
dielectric continuum models or by computing solvent distribution 
functions around solute systems. In this talk, the basic concepts of 
solvation modeling frameworks will be presented and illustrated. 
After de-veloping the hierarchy of models, particular attention will be 
paid to analytical theories based on the statistical-mechanical integral 
equation formalism. While originally de-veloped for simple liquids 
these methods have been adapted over the years to be ap-plicable to 
complex biomolecular scenarios [1,2]. Due to the massive reduction of 
the number of degrees of freedom compared to atomistic simulations, 
such a framework can also be coupled to polarizable potential mod-
els as well as to a quantum-mechanical description of solute-solvent 
interactions, thus allowing for enhanced pre-dictive capabilities [3,4]. 
Several example applications will be presented, including hy-dration 
patterns around biomolecules, chemistry under extreme thermody-
namic condi-tions, and complicated problems of coupled protomeric, 
tautomeric [5] and conforma-tional equilibria of drug-like molecules in 
solution.
Page 5 of 27 J Cheminform 2016, 8(Suppl 1):S18
References
1. Kast SM, Heil J, Hoffgaard F: Integral equation theory as a solvation model 
for classical and quantum solute systems. In Sutmann G, Grotendorst J, 
Gompper G, Marx D, editors. Computational trends in solvation and trans‑
port in liquids. Jülich: IAS Series vol 28; 2015. p. 419–34.
2. Kast SM, et al.: A minimalist model for ion partitioning and competition in a 
K+ channel selectivity filter. J Gen Physiol 2011;138:371–3.
3. Kloss T, Heil J, Kast SM. Quantum chemistry in solution by combining 3D 
integral equation theory with a cluster embedding approach. J. Phys. Chem. 
B 2008;112:4337–43.
4. Frach R, Kast SM. Solvation effects on chemical shifts by embedded cluster 
integral equation theory. J Phys Chem A 2014;118:11620–8.
5. Kast SM, et al. Prediction of tautomer ratios by embedded cluster integral 
equation theory. J Comput‑Aided Mol Des. 2010;24:343–53.
O11  
An integrated chemical, biological and pathological in silico 
approach towards identifying potent drug combinations
Krishna C. Bulusu, Andreas Bender
Centre for Molecular Informatics, Department of Chemistry, University 
of Cambridge, UK, CB2 1EW
Correspondence: Krishna C. Bulusu ‑ kcb27@cam.ac.uk 
Journal of Cheminformatics 2016, 8(Suppl 1):O11
Recent technological advancements in the field of health science 
brought with it a deluge of data that is waiting to be interpreted. It 
is critical to understand the information that can be derived from 
this wealth of data to not just identify the chemical, biological and/or 
genetic markers/patterns of a particular disease but also to utilize this 
knowledge to design more potent and selective medicines. However, 
partly driven by the urgency of this need, we are generating more data 
than we are able to analyze and interpret.
Most diseases display a ‘pathological footprint’ on a systems biology 
level, even if the observed phenotype is localized to a tissue or organ. 
In order to understand and explain such activity, integration of bio-
logical and chemical information such as chemical fingerprints with 
bioactivity profiles, gene expression patterns, pathway annotations, 
protein interaction networks etc., is vital. This study focuses on inte-
grating experimentally derived chemical, biological and pathological 
data to identify and explain compound mode-of-action and its impact 
on disease regulation. Such analysis will not only help define a thera-
peutic approach towards more efficient and less promiscuous drugs, 
but also expedite this process by identifying current approved drugs 
for repurposing that could potentially reverse disease signatures. 
Drug combinations, which has been shown previously to be a strong 
approach towards tackling the issues of drug resistance and specific-
ity, will be the primary focus of this study.
This talk will highlight in silico approaches towards next-generation 
drug discovery along with relevant resources and datasets that are/
can be integrated to achieve a ‘systems biology’ picture of disease pro-
gression and regulation.
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Statistical modeling (also termed QSAR/QSPR) is a general name for 
a host of methods that correlate a specific activity for a set of com-
pounds with their structure-derived descriptors by means of a math-
ematical model. The method has been widely applied in many fields 
including chemistry, biology, and environmental sciences with a par-
ticular emphasis in drug design.
In recent years less “traditional” QSAR studies have emerged focusing 
for example on the design of food, cosmetics and oil products, high 
energy materials and solar cells. These QSAR models are often referred 
to as M(material)QSAR and form part of the now growing field of 
Material Informatics.
This seminar will focus on the application of statistical modeling tech-
niques in material sciences discussing, through selected applications, 
methods typically used in this field (e.g., PCA, Clustering and linear and 
non-linear regression), material descriptors (e.g., material composition, 
material spectra which are particularly useful when the exact com-
position / structure of the material are unknown) and the challenges 
in obtaining them. Special emphasis will be put on the application 
of MQSAR in the design of photovoltaic (PV) cells of various types. In 
particular cells entirely made of metal oxides (MO) have the potential 
to provide clean and affordable energy if their power conversion effi-
ciencies are improved. Such improvements require the development 
of new MOs which in turn could benefit from combining combinato-
rial material sciences for producing solar cells libraries with statistical 
tools to direct synthesis efforts. For this purpose we developed a QSAR 
workflow with several novel components [1,2] and applied it to the 
analysis of a diversity of solar cell libraries [3]. Our results demonstrate 
that MQSAR models with good prediction statistics for multiple solar 
cells properties could be developed and that these models highlight 
important factors affecting these properties in accord with experimen-
tal findings. The resulting models are therefore suitable for designing 
better solar cells. We further demonstrate that the similar property 
principle commonly invoked in pharmaceuticals design could be 
extended to PV cells.
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Determination of similarities between protein binding pockets is an 
important challenge in computer-aided drug design. To this end, 
Cavbase was developed as a tool for the automated detection, stor-
age, and classification of putative protein binding sites [1]. Binding 
sites are characterized as sets of pseudocenters, which denote sur-
face-exposed physicochemical properties, and can be used to enable 
mutual binding site comparisons. However, these comparisons tend to 
be computationally very demanding and often lead to very slow com-
putations of the similarity measures.
In this contribution, improved and accelerated methods for the com-
parison of protein binding sites are presented. We propose a novel 
and efficient modeling formalism that does not increase the size of the 
graph model used in Cavbase, but leads to graphs containing consider-
ably more information assigned to the nodes, due to the introduction 
of additional descriptors which consider local surface characteristics. 
Combined with a heuristic for the efficient detection of maximum com-
mon subgraphs, this leads to a gain of information and enables much 
faster but still very accurate comparisons between different structures. 
Moreover, another accelerated version is discussed which makes use 
of graph partitioning [3]. Therefore, graphs are split into disjoint com-
ponents with regard to pseudocenter types prior to their comparisons. 
This leads to seven much smaller graphs than the original one and thus 
to another significant speed-up with only a small loss of accuracy.
Finally, a program is introduced, which allows for ultra-fast similarity 
comparisons, as protein binding sites are represented by sets of dis-
tance histograms that are both generated and compared with linear 
complexity [4]. This method attains a speed of more than 20,000 com-
parisons per second, which makes screenings across large datasets 
and even entire databases easily feasible. The practical use of the 
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new methods is proven by a successful prospective virtual screening 
study that aimed at the identification of novel inhibitors of the NMDA 
receptor.
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Fragment-based methodologies have become an alternative to con-
ventional High Throughput Screening during the last decade [1]. One 
of the advantages is the higher hit rate due to the much smaller frag-
ment space. Identified hits not only serve as starting points for drug 
design but also represent sweet spots in the chemical space. Further 
development can therefore be promoted by sampling the chemical 
around the fragment hits.
This was applied to evolve fragment hits identified through a 3D 
pharmacophore-based virtual screening [2] against the viral 3C pro-
tease via fragment growing. At first fragment growing was carried out 
through a de novo design [3] workflow in which the fragment hit core 
is combined with tangible chemical building blocks via organic syn-
thesis reactions encoded as SMIRKS patterns to ensure synthetic fea-
sibility later on. To select de novo designed fragment hit analogues for 
chemical synthesis the generated library was analyzed through virtual 
screening for target binding along fragment growing vectors defined 
through structure-based design and for chemical space population by 
principle component analysis. A subset with promising binding char-
acteristics was selected for chemical synthesis and subsequent bio-
logical evaluation.
In this work we show how fragment growing can be supported by 
efficient chemical space sampling to suggest promising de novo 
designed analogues, which are synthetically feasible and thus enable 
rapid fragment growing.
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Modelling protein flexibility is still a highly challenging objective in 
various fields of computer aided drug design. Many applications make 
use of structure ensembles as a convenient way for incorporating 
structural variability of proteins. Due to the steadily growing amount 
of available protein structures, alternative conformations can mean-
while be provided for a multitude of different targets. However, 
ensemble generation is mostly a time-consuming process which often 
requires manual interaction. In order to simplify the usage of protein 
ensembles, we developed a fully automated preprocessing workflow 
for the enrichment and the analysis of protein flexibility information 
[1]. In a first step, alternative conformations of a given binding site are 
extracted from an arbitrary selection of protein structures, e.g. the cur-
rent version of the Protein Data Base (PDB). Using an indexed database 
that has been specially geared to this purpose makes this step highly 
efficient. Afterwards, the resulting structures are being aligned with 
our new active site alignment algorithm ASCONA [2] which has been 
developed with a focus on an accurate detection of protein backbone 
variations. Based on the active site alignment, a further step detects 
flexible regions within the binding site and uses a remaining rigid core 
for a superimposition of the generated ensemble. If required, a subse-
quent filtering reduces the ensemble to a set of relevant protein con-
formations. Finally, the resulting ensemble structures are protonated 
with our hydrogen prediction tool Protoss [3], considering tautomer-
ism and protonation states of both protein and ligand molecules. In 
summary, our preprocessing workflow constitutes a very convenient, 
reliable, and particularly fast way to generate structural ensembles for 
any application of interest.
References
1. Bietz S, Rarey M. SIENA: Efficient compilation of selective protein binding 
site ensembles. J Chem Inf Model. submitted.
2. Bietz S, Rarey M. ASCONA: Rapid detection and alignment of protein bind‑
ing site conformations. J Chem Inf Model. 2015;55:1747–56.
3. Bietz S, Urbaczek S, Schulz B, Rarey M. Protoss: a holistic approach to predict 
tautomers and protonation states in protein‑ligand. J Cheminf. 2014;6:12.
O16  
ChemPLPXB: implementation of QM‑based terms for the 
recognition of halogen bonding in drug design
Markus O. Zimmermann, Andreas Lange, Manuel Ruff, Johannes Heidrich, 
Ionut Onlia, Thomas E. Exner, Frank M Boeckler
Department of Pharmaceutical and Medicinal Chemistry, Eberhard Karls 
University Tuebingen, Germany
Correspondence: Markus O. Zimmermann ‑ frank.boeckler@uni‑tuebin‑
gen.de 
Journal of Cheminformatics 2016, 8(Suppl 1):O16
Halogen bonding is rapidly gaining recognition in medicinal chemis-
try and related fields with a concomitant need for reliable evaluation 
of the quality of the interaction [1]. Several MM parameterizations 
and QM/MM methods have been recently developed to facilitate the 
study of these interactions. We extensively used QM model calcula-
tions on the MP2/TZVPP-level of theory to systematically map the 
relationship between strength and geometry of halogen bonds to dif-
ferent interaction partners (carbonyl backbone, sulfur contacts, nitro-
gen contacts, carboxylates, and π-systems) [2–4]. We evaluated the 
potential for molecular design of additional halogen bonds in existing 
protein-ligand complexes of the PDB by applying XBScore, our first 
QM-derived scoring function for the recognition of contacts to the car-
bonyl backbone [5]. This approach has been experimentally validated 
on the protein kinase p38α with halogenated ligands using DSF and 
FP assays. In addition, we used support vector regression to develop a 
QM-based scoring function for the recognition of halogen bonds tar-
geting methionine. We integrated both scoring functions in ChemPLP 
and investigated their potential to improve pose retrieval for a test set 
of crystal structures featuring halogen bonds.
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Computational approaches have become indispensable for drug 
design campaigns but also as auxiliary tool for structural biology [1]. 
In the field of G protein coupled receptors (GPCRs), the combination 
of in silico methods and pharmacological experiments represent a 
strong alliance for novel functional insights. Recent achievements in 
GPCR crystallography provide us with new structural data on GPCRs. 
However, these structures represent only single static views of highly 
flexible proteins. The combination of crystallographic data with state-
of-the-art computer-driven simulations allows for a mechanistic view 
on this highly important class of drug targets. Taking muscarinic 
acetylcholine receptors (MAChRs) as representative examples we 
explained, how GPCRs can be modulated in a ligand dependent and 
predictable manner.
Starting from carefully developed homology models of MAChRs, 
extensive binding mode analyses were performed by means of 
protein-ligand docking and 3D pharmacophore modeling. In order 
to sample the flexibility and the dynamic properties of the receptor-
ligand complexes we carried out all-atom molecular dynamics simu-
lations [2]. This combination led to mechanistic GPCR models that 
comprise both inactive and active-like receptor states. After charac-
terization of the orthosteric binding pocket, we focused on dualsteric 
ligand binding [3]. Such ligands simultaneously bind to the orthosteric 
and the allosteric binding site and combine the high affinity of orthos-
teric ligands with the high specificity of the allosteric binding site.
We show, for the first time, the structural basis for dualsteric GPCR 
modulation on a molecular level. Our functional GPCR models are 
able to rationalize subtype selectivity and biased signaling. Addition-
ally, our models explain a novel concept for partial agonism, termed 
dynamic ligand binding. Taken together, our dynamic models illus-
trate how distinct conformational states can be stabilized in a ligand-
dependent manner. This offers the possibility to rationally design 
specific modulators for MAChRs but also for other GPCRs.
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CO2 absorption in ionic liquids (ILs)—which are suitable solvents with 
tunable properties—caught great interest of scientists in the last dec-
ade. Having a huge variety of possible ILs (~1015) the CO2 solubility can 
vary strongly with selected ions. In order to save the time for choosing 
the most promising IL candidates from the experiment, we suggest 
simple theoretical protocols to predict the CO2 absorption behaviour 
of ionic liquids [1]. It was found that strong interaction with the anions 
of the IL, i.e., the formation of carboxylates with O-C-O angles <140°, 
corresponds chemical absorption whereas weak interaction (O-C-O 
angle >170°) indicates physical absorption (Fig.  3). A predictive esti-
mate with a clear exact distinction between physical and chemical 
absorption can be simply obtained by carrying out the geometry opti-
mization in the presence of a solvation model instead of optimizing it 
only in gas phase as has been done so far. From these solvated geom-
etries free energies are derived which compare very well with experi-
ment [2]. We also correlate the calculated energies with experimental 
gas capacities (mol CO2 per mol IL), in order to estimate the potential 
capacity close to the room temperature. Within the suggested pro-
tocol the most promising anions, potentially useful to design ionic 
liquids for reversible chemical absorption of CO2, are defined by the 
reaction Gibbs free energy in a range from −30 to 16 kJ mol−1.
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Antagonizing the human M3 muscarinic receptor (hM3R) over a long 
time is a key feature of modern bronchodilating COPD drugs aiming at 
symptom relief. The long duration of action of the antimuscarinic drug 
tiotropium and its kinetic subtype selectivity over hM2R have been inves-
tigated by kinetic mapping of the binding site and the exit channel of 
hM3R. Hence, dissociation experiments have been performed with a set 
of molecular matched pairs of tiotropium on a large variety of mutated 
variants of hM3R. The exceedingly long half-life of tiotropium (of more 
than 24 h) is attributed to interactions in the binding site; particularly a 
highly directed interaction of the ligands’ hydroxy group with an aspara-
gine (N5086.52) prevents rapid dissociation via a snap-lock mechanism. 
The kinetic selectivity over hM2R, however, is caused by differences in 
the electrostatics and in the flexibility of the extracellular vestibule.
Extensive molecular dynamics (MD) simulations based on the M3R 
X-ray structure are performed and various unexpected changes in 
receptor flexibility and solvent networks upon ligand binding are 
Fig. 3 Binding energy versus O‑C‑O angle for the anion‑CO2 com‑
plexes optimized in gas‑phase (A) and including continium solvation 
model (B)
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seen. Minor changes in the ligand structure can lead to breathing-
motions on long time-scales of the entry channel in hM3R and 
only the most optimized ligand (i.e. tiotropium) tends to freeze 
all large scale movements. Similar effects are seen in MD simula-
tions of mutated receptor variants. These observations may help 
to understand differences in residence times of various ligands. 
Investigations like this may prove to be useful to qualitatively pre-
dict differences in receptor residence times for structurally closely 
related ligands.
Putting together the pieces: building a reaction-centric electronic lab 
notebook for mobile devices.
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Protein kinases are involved in a variety of diseases including cancer, 
inflammation, and autoimmune disorders. Thus, the development 
of new kinase inhibitors has been a major focus in pharmaceuti-
cal research over the last decades. Although, this resulted to date 
in 25 FDA approved drugs, only a small subset of kinases are estab-
lished key targets, while most kinase inhibitors are unintentionally 
promiscuous.
Using the wealth of available kinase structures—i.e. over 3600 
PDB structures—we analysed the druggability of the entire human 
kinome and prioritized (yet) untapped kinases for drug discovery 
efforts [1]. For this, representative kinase structures were selected 
and the missing part of the kinome was modelled via homology 
modelling. DoGSiteScorer [2] was used to calculate geometrical and 
physicochemical properties of the ATP pockets and to predict the 
potential of each kinase to be druggable. The results indicate that—
from a structural perspective—around 75% of the kinome have 
binding site characteristics that should allow the design of drug-like 
compounds. Top ranking structures comprise kinases that are pri-
mary targets of known approved drugs but additionally point to so 
far less explored kinases.
Several aspects will be discussed including the top ranking kinases, 
the information gained from experimental hit rates [3] as well as our 
attempts to use structural information to enhance compound selectivity.
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Extensive classical molecular-dynamics simulations including meta-
dynamics enhanced sampling reveal three distinct binding sites for 
arginine vasopressin (AVP) at its V2-receptor (V2R). Two of these, the 
vestibule and intermediate sites, block (antagonize) the receptor and 
the third is the orthosteric activation (agonist) site. The contacts found 
for the orthosteric site satisfy all the requirements deduced from 
mutagenesis experiments, including the involvement of residues near 
the extracellular N-terminus of the receptor. The biologically active 
conformation of AVP has been determined for each binding site. Meta-
dynamics simulations on V2R and its V1aR-analog give an excellent cor-
relation with experimental binding free energies by assuming that the 
most stable binding site in the simulations corresponds to the experi-
mentally determined binding free energy in each case. We extended 
our results to the β2-adrenergic receptor to study the co-operative 
mechanism of the ligand and G-protein on GPCR activation. The result-
ing three-site mechanism for both β2 and V2-activity is compatible 
with the ternary complex model.
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Increased computational performance makes possible MD simulations 
of biologically relevant timescales exceeding 1 µs, which can be used 
to sample the conformational space of proteins. Of the available meth-
ods, the brute force method has the advantage of being highly analo-
gous to the actual processes and of using little a priori knowledge [1]. 
In this work, we sought methods that can be useful for interpreting 
the vast amount of data associated with these kinds of simulations.
The system under investigation, the p53 core domain, has several loop 
regions protruding from a stable β-barrel that B-factor plots suggest to 
be flexible. Cluster analysis of simulations several microseconds long 
showed that no structural convergence is reached for the system. Sub-
sequently, the flexible regions were investigated individually.
A set of cluster analyses were performed, in which only residues of one 
individual region were regarded in each. This vastly simplified data 
allowed reoccurring structures to be identified, while it also showed 
that no convergence is reached for the individual regions. Structural 
homogeneity within clusters, and structural differences between clus-
ters with high RMSD differences of those individual regions, can be 
shown by hydrogen-bond analyses. They can also show thermody-
namic explanations for sudden changes in the RMSD trajectory of the 
different regions. Clustering of the flexible loop regions using a DASH 
analysis [2], which is based on torsional angles, showed a good match 
to the results of Cartesian clustering based on atomic positions. Corre-
lation analysis showed that flexible regions are mostly isolated by the 
β-barrel and move independently as long as they have no direct con-
tacts and none of the regions makes a large move.
These analyses show that regarding flexible regions individually can 
improve the evaluation of the incompletely sampled conformational 
space of a protein. This knowledge can then be used when it is com-
pared with a similar system like a mutated or complex-bound version 
of the protein.
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Accurate assessment of the conformational space of drug-like mol-
ecules in free solution is a frequently underestimated, yet relevant 
ingredient of molecular design. In particular, predicting and control-
ling free ligand conformations is essential for minimizing the entropic 
penalty to reorganize a ligand’s geometry upon binding to a protein. 
Overcoming the deficiencies of common small molecule force fields 
represents a particular challenge due to the considerable computa-
tional cost of high-level quantum-chemical calculations for predicting 
the conformational manifold.
Here, we demonstrate the performance of a hierarchical filtering 
scheme that allows for the identification of dominant conformations 
together with their proper statistical weights measured by their free 
energies in solution with quantum-chemical accuracy. The automated 
workflow implies a sequence of force field-based high-temperature 
molecular dynamics simulations using implicit solvent models, clus-
tering and filtering steps, and high-level geometry optimizations in 
solution employing the polarizable continuum model (PCM) as well 
as the embedded cluster reference interaction site model (EC-RISM) 
[1] for scoring, and calculation of theoretical NMR spectra [2] to be 
compared with experiments. We apply the workflow to variants of 
the protein kinase inhibitor WZ4002 and several novel EGFR inhibi-
tors that are highly active against a drug-resistant mutant of the 
epidermal growth factor receptor (EGFR-T790M) [3–5]. The relative 
significance of conformational preconfiguration in comparison with 
modulation of direct protein-ligand interactions upon chemical sub-
stitution is discussed.
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Halogen bonding is a rather new type of non-classical interac-
tion. Recently, the field of halogen bonding has attracted much 
attention in life sciences and drug discovery [1–4] and various 
halogen bonding examples have been reported and shown to be 
viable. Therefore, halogen bonding needs to be integrated into the 
molecular and drug design process. This talk presents a new scor-
ing function for the halogen bonding interaction between halo-
genated molecules and the side chain sulfur of methionine based 
on quantum chemical calculations using the MP2/TZVPP level of 
theory. For this purpose, we have extended our previously reported 
QM studies quite significantly [5] by an exhaustive, systematical 
generation and evaluation of interaction geometries using small 
model systems. From this data, we derived two separate scoring 
terms for the interaction using support vector regression and 4-fold 
cross validation: a σ-hole factor and a SphericalScore. The σ-hole 
factor describes the directionality of the interaction and the Spheri-
calScore addresses the spatial position of the halogenated ligand 
around the sulfur atom. A combination of these two scoring terms 
yields the overall halogen bonding score. Validation was done 
through randomly generated interaction geometries not contained 
in the original data. Concomitant evaluation of these geometries 
through QM calculations and prediction through the scoring func-
tion showed very good correlations. The herein presented scoring 
function is a blueprint for integration into empirical scoring func-
tions and docking programs.
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Water molecules play integral roles in the formation of many pro-
tein-ligand complexes, and recent computational efforts have been 
focused on predicting the thermodynamic properties of individual 
waters and how they may be exploited in rational drug design. How-
ever, when water molecules form highly coupled hydrogen bonding 
networks, there is, as yet, no method that can rigorously calculate the 
free energy to bind the entire network, or asses the degree of coopera-
tivity between waters.
In this work, we revisit the grand canonical Monte Carlo simulation 
technique [1] and show how it can be used to calculate efficiently the 
binding free energies of water networks of arbitrary size and complex-
ity. Using a single set of simulations, our methods can locate waters, 
estimate their binding affinities, capture the cooperativity of the 
water network, and evaluate the hydration free energy of entire pro-
tein binding sites. Our techniques have been applied to multiple test 
systems and compare favourably to thermodynamic integration simu-
lations and experimental data. The implications of these methods in 
drug design will be discussed.
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The complexity and diversity of chemical transformations involved 
in drug metabolism renders Site of Metabolism (SoM) prediction dif-
ficult [1]. One strategy to increase performance of machine-learning 
models is to develop appropriate molecular representations in terms 
of new descriptors. Quantum-chemically derived molecular descrip-
tors encoding the reactivity of individual atoms appear to be an intui-
tive starting-point for model improvements. Here, we address the 
challenge of SoM prediction with descriptors based on atomic partial 
charges. To this end we assessed various partial charge schemes with 
respect to their dependence on quantum mechanical methods as well 
as their dependence on molecular conformation and charge state [2]. 
Based on the results of this study, we implemented various atomic 
reactivity descriptors derived from the atomic charge neighborhood 
information. These descriptors performed well for the task of predict-
ing cytochrome P450 SoMs in drug molecules. The methodological 
concept is generally applicable to reactivity prediction and not limited 
to metabolism.
References
1. Kirchmair M, Göller AH, Lang D, Kunze J, Testa B, Wilson ID, Glen RC, Schnei‑
der G. Predicting drug metabolism: experiment and/or computation? Nat 
Rev Drug Discov. 2015;doi:10.1038/nrd4581.
2. Finkelmann AR, Göller AH, Schneider G. Manuscript in preparation.
O27  
Integrating Chemoinformatics and Quantum Chemistry 
for computational electrochemistry: the search for new electrolyte 
materials
Tamara Husch1, Christoph Schütter2, Andrea Balducci2, Martin Korth1
1Institute for Theoretical Chemistry, Ulm University, 89081 Ulm, Germany; 
2Helmholtz Institute Ulm, Karlsruhe Institute of Technology, 89081 Ulm, 
Germany
Correspondence: Martin Korth ‑ martin.korth@uni‑ulm.de 
Journal of Cheminformatics 2016, 8(Suppl 1):O27
Molecular materials are a crucial component of electrochemical stor-
age devices like Lithium ion batteries [1]. Electrolyte solvents for 
instance have a strong influence on all relevant properties of the 
electrolyte, which in turn has great impact on the performance of the 
storage device. Physical limitations of electrolyte solvents are more 
and more often found to be roadblocks for the further improvement 
of batter technology [1]. Despite this, only a tiny fraction of the large 
number of possible solvents has been experimentally investigated, 
because experimental high-throughput work is complicated and 
costly. Computational work at the atomic scale on the other hand is 
still in the early stages in this field [2]. Like many parts of materials sci-
ence, battery research is dominated by Solid State Physics, though in 
the case of molecular materials, methods from Quantum Chemistry 
and Chemoinformatics offer many much needed opportunities. We 
have made first steps to integrate existing computational approaches 
from these fields as well as Chemical Engineering within a tool-box for 
the design of optimization of liquid electrolyte systems as a filter for 
subsequent experimental work [3–5]. In addition, combinatorial Quan-
tum Chemistry based tools were developed to estimate complex prop-
erties related to the reactivity of electrolyte materials with each other 
and with electrode materials. We have then investigated the known 
chemical space and complete subspaces of the most promising com-
pound classes for new electrolyte materials.
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We have previously developed a 3D virtual screening library of >3,000 
compounds derived from Central African flora [1,2] and evaluated the 
pharmacokinetics profile [3]. This work has been extended to include 
West Africa [4], North Africa and Southern Africa, as well as a small 
library of compounds with remarkable potencies from African flora [5], 
including anti-mycobacterial infections, malaria, onchocerciasis and 
cancer [6]. In this work, we present an SQL platform for searching natu-
ral products for drug discovery from African medicinal plants. Data has 
been collected from major natural products journals and PhD theses 
from university libraries. The unified library contains > 5,000 unique 
structures from all regions of the African continent. The known uses of 
the plant species in African Traditional Medicine (ATM) have been pre-
viously related with the measured biological activities of the isolated 
plant metabolites [7]. Apart from the pan-African natural products 
library [8], each compound in this library is linked to known biologi-
cal activities, as well as several physicochemical properties that can be 
used to evaluate drug-likeness. 3D structures are available for virtual 
screening purposes and each compound was classified to a chemical 
class, known biological activities and the plant species from which 
the compound was originally isolated. All compounds are available 
for download, thus the present data supports computer-aided drug 
design (CADD) and virtual screening (VS) campaigns.
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Cancer stands amongst the most common disease-related causes of 
death; with ~7.6 million deaths within the human population and is 
expected to worsen in some few decades [1]. Previous studies have 
shown that about 48% of anticancer drugs approved were either natural 
products (NPs) or directly derived from NP lead compounds by semi-syn-
thesis [2]. Our goal is to develop a small potent and less toxic NP library 
for virtual screening within the African setting. Computer-aided drug 
design methods, has become a promising part of the drug discovery 
process nowadays. This study was focused on generating a 3D structural 
library of potential anticancer compounds from the African flora and to 
evaluate the “drug-likeness” and toxicity of the new compound library. 
Virtually screening and in silico toxicity assessment were carried in com-
parison with the dataset of Naturally Occurring Plant-based Anticancer 
Compound-Activity-Target (NPACT), comprising ~1,500 published natu-
rally occurring plant-based compounds from around the world [3]. From 
this study, about 400 compounds have been identified from African flora 
and their drug-likeness properties evaluated in comparison with NPACT 
and DNP. A successful docking attempt was carried out for some four-
teen selected known anticancer drug targets [4]. Pharmacophore-based 
virtual screening and in silico toxicity assessment have also been done. 
Pharmacophore models were validated through receiver operating char-
acteristic (ROC) and Güner-Henry (GH) scoring methods [5], indicating 
that several of the models generated could be useful for the identifica-
tion of potential anticancer agents from natural product databases. The 
validated pharmacophore models were used as 3D search queries for 
virtual screening of the AfroCancer, along with the NPACT. Additionally, 
the in silico assessment of toxicity of the two datasets was carried out by 
use of eighty eight (88) toxicity end points predicted by Lhasa’s expert 
knowledge-based system (Derek) [6], showing that only an insignificant 
proportion of the promising anticancer agents would be likely to show 
high toxicity profiles. Diversity analysis of the AfroCancer and NPACT 
datasets was carried out using the analysis of principal components [7].
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There is widespread concern about the toxicological effects of 
man-made chemicals in the environment, including those of phar-
maceutical products and their metabolites. There are databases 
of, and computer models to predict, aquatic narcosis and, in some 
cases, excess aquatic toxicity such as ECOSAR [1] but there remains 
a need for better sharing of human knowledge about the full range 
of environmental and human toxicological hazards. Computer 
programs such as Derek [2] are used to share human knowledge 
about mammalian toxicity and a proof of concept application, 
Eco-Derek, using the same technology to share knowledge about 
toxicity to the ciliate Tetrahymena pyriformis and human skin sen-
sitisation has been described [3]. We are developing new alerts 
covering other species not included in the original knowledgebase 
for Eco-Derek. The knowledgebase currently contains 52 alerts, 
207 patterns, 138 reasoning rules, 79 literature sources, 5 species 
and 6 toxicity endpoints. For mammalian toxicity, Derek reports 
confidence in predictions of activity, or likelihood that activity 
will be seen, using terms such as “probable”, “plausible”. Eco-Derek 
reports the estimated potency of toxicity of a query chemical to 
T. pyriformis, using terms such as “High”, “Moderate”, “Low”. It takes 
into account both narcosis and mechanism-based toxicity (often 
called “excess toxicity” in cases where it is more severe than nar-
cosis). The new knowledge-based system for predicting envi-
ronmental toxicity is being built using the Nexus platform from 
Lhasa Limited [4]. It is intended that the system will report both 
potency and confidence in predictions (e.g. “Predicted toxicity to 
fish: Moderate. Confidence in the prediction: High”). Nexus cur-
rently only supports reporting of confidence (likelihood). So, for 
the present, knowledge about toxicity to T. pyriformis contained in 
eco-Derek has been reworked and assessed in terms of confidence 
about its predictive reliability and incorporated into the new sys-
tem. In addition to the knowledge base, a database covering the 
environmental toxicity of chemicals is being built, emphasising, 
but not restricted to, aquatic toxicity, with effort concentrated on 
data from African sources not previously easily-accessible elec-
tronically. The data are being studied to develop new rules for 
the knowledge base of the prediction system. Species covered 
include Daphnia magna, Escherichia coli, Pseudokirchneriella sub-
capitata, Danio rerio, Pimephales promelas etc. The prediction sys-
tem will be demonstrated during the presentation if time allows, 
and will be available for demonstration during conference breaks. 
We have currently incorporated the Eco-Derek knowledge into 
Lhasa’s Nexus platform. The purpose of this project is to facilitate 
the exchange of knowledge about environmental toxicity between 
scientists. It is a collaborative effort between disciplines and across 
continents. The authors invite and encourage other scientists to 
become involved.
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The modelling of the chemical stage of radiobiological mechanism 
may be very helpful in the study of the radiobiological effect of ion-
izing radiation when the water radicals formed by the densely ionizing 
ends of primary or secondary charged particles react with DNA mol-
ecules in living cells and damage them. These radicals arise in clusters 
that diffuse while the radicals react mutually or with other species 
(radiomodifiers) present in water medium; oxygen and N2O being very 
important. The proposed mathematical model has been created with 
the help of Continuous Petri nets. It enables us to describe and study 
the influence of both the main parallel processes: chemical reactions 
and diffusion of radical clusters. It is possible to study the time change 
of concentration of individual radicals during this diffusion process, 
which may be very helpful when the efficiency of different substances 
present in medium in the DNA damage (radiobiological effect) is to be 
studied. We have started to study the corresponding problem earlier; 
the contemporary result of chemical reactions and cluster diffusion 
having been described with the help of corresponding differential 
equations. The given model has been applied to the experimental data 
obtained for Co60 radiation (see [1]). Continuous Petri nets have been 
then used to simulate time dynamics of chemical stage under anoxic 
conditions (see [2]). Oxygen (if present) may act in two different direc-
tions: at small concentrations the interaction with hydrogen radicals 
prevails and final biological effect diminishes while at higher concen-
trations additional efficient oxygen radicals may be formed. Molecules 
N2O react then with hydrated electrons; the number of OH radicals 
increases, which results in a greater damage of DNA molecules.
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Our research focuses on the development of chemoinformatics meth-
ods and algorithms to design new functional electroceramic materi-
als. Ceramic materials are widely used in electrochemical devices such 
as oxygen separation membranes, solid oxide fuel cell (SOFC) cath-
odes, dielectric materials etc. Solid oxide fuel cells are of great inter-
est as economical, clean and efficient power generation devices. Fuel 
cells have several advantages over conventional power generation 
techniques. They characterized by high-energy conversion efficiency 
and high power density. The propagation of mobile telecommunica-
tion technologies require the development of new ceramic materials 
that can be used as dielectric resonators and filters. Due to the diffi-
cult and time consuming process of conventional compound synthe-
sis, the development of materials often joins experimental synthesis 
efforts with in silico materials design [1]. Studying materials with a 
complex phase structure as well as the prediction of the properties of 
materials obtained under different conditions are of particular interest.
In this study we propose methods and descriptors efficient for the 
assessment of “composition-structure-functional property” relationship. 
Involved approaches include complementary machine learning methods.
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The representation of the relevant conformational space of small 
molecules (e.g. drug-like molecules) is a thoroughly studied, non-
trivial problem. A wide variety of different methodologies have been 
explored, with the aim to devise an algorithm that achieves optimum 
performance with respect to accuracy, conformational ensemble size, 
and computing time.
Here, we present a comprehensive benchmarking study, in which we 
assess and compare the performance of a variety of free and commer-
cial tools for computing conformer ensembles. Inspired by the Iridium-
HT benchmarking dataset [1], we have devised a new, high-quality 
library of protein-bound ligand conformations from the PDB, with the 
aim to improve statistical significance by use of a substantially larger 
dataset, while adhering to strict quality criteria.
Our benchmarking tests show that several freely available conformer 
ensemble generators (e.g. RDKit [2], Balloon [3], CONFECT [4]) achieve 
a level of accuracy which is comparable to that of commercial software 
(e.g. MOE [5]). However, substantial differences with respect to runt-
imes and the percentage of molecules for which the algorithms fail to 
produce any solutions can be observed. Also, longer computing times 
do not per se lead to better conformer ensembles. From this statistical 
analysis we devised guidelines on how to parameterize tools for best 
performance in different application scenarios (e.g. computation of 
small data sets with maximum accuracy vs. large-scale virtual screen-
ing applications).
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Matched Molecular Pairs is a well-established concept in Medicinal 
Chemistry which was successfully employed for optimization of phar-
macokinetic or physicochemical properties [1]. Several recent publica-
tions from different groups suggest the extension of the MMP towards 
structure-based lead optimization in context of protein environment 
[2,3]. We introduce a strategy to relate the substitution effect within 
MMPs to the atom environment within the co-crystallized protein-
ligand complex implemented within the VAMMPIRE database and the 
supplementary web interface (http://vammpire.pharmchem.uni-frank-
furt.de) [4].
In this presentation we discuss different applications of the VAMMPIRE 
database. VAMMPIRE-LORD (lead optimization by rational design) 
describes an innovative strategy to improve the binding affinity of a 
defined lead compound using 3D-MMPs [5]. We demonstrate that 
the created model is able to extrapolate the knowledge of a chemical 
transformation and the associated effect on ligand affinity to any simi-
lar system. In a second application we discuss the use of a subset of 
the VAMMPIRE database for validation of scoring functions. Co-crystal-
lized 3D-MMPs with measured affinity data are suitable for evaluation 
of scoring functions independent from the underlying docking algo-
rithm. We present our findings considering the performance of scor-
ing functions on the validation dataset derived from the VAMMPIRE 
database.
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One of the most widely used molecular similarity metrics to cluster 
large compounds sets is 2D fingerprint-based Tanimoto distance, due 
the overall good balance between speed and effectiveness [1]. How-
ever, there are significant limitations in the ability of a 2D fingerprint-
based method to capture the biological similarity between molecules, 
especially when conformationally flexible structures are involved. 
Structures which appear to largely differ in terms of 2D structure may 
give rise to quite similar steric/electrostatic properties (Fig.  4), which 
are what actually determine their recognition by biological macromol-
ecules [2].
We were recently confronted with the task of clustering a collec-
tion of building blocks for drug discovery consisting of about 800K 
heterocyclic scaffolds with variable functional group decoration. The 
structural diversity of this collection was not adequately captured by 
2D ECFP4 fingerprint Tanimoto distances, as shown by the rather flat 
distribution of 2D similarity values across the set, and by their lack of 
correlation with the 3D similarity metrics.
The initial step of any clustering procedure is the computation of an 
upper triangular matrix holding similarity values between all pairs of 
compounds.
This step becomes computationally demanding when using 3D meth-
ods, since an optimum alignment between the molecules needs be 
found taking into account multiple conformers.
The talk will cover the methodological and technical solutions 
adopted to enable 3D clustering of such a large set of compounds. 
Selected examples will be presented to compare the quality and the 
informative content of 3D vs 2D clusters.
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Plastics and its residues are washed into sea with severe consequences 
for the marine environment [1]. Due to the similar structure of some 
natural and synthesized polymer compounds (e.g. polyamides) it 
is difficult to estimate the real amount of plastic marine litter [1]. 
Fig. 4 3D Cresset similarity for this pair of molecules is 0.723, whereas 
2D ECFP4 fingerprint similarity is only 0.185. Electrostatic field isocon‑
tours and field point extrema are shown
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Furthermore, identification by reference spectra libraries does not suc-
ceed in combination with contaminated and / or degraded micro plas-
tics. A new robust characterization method for high spatial resolution 
FTIR microscopy, using vibration band patterns to obtain specific char-
acteristics for qualitative analysis, is introduced in the present study.
Several polymer types (PE, PP, PA, bio polymers) in different sizes 
(macro and micro particles) and different qualities (new, recycling, 
plastic marine litter) were measured in transflection mode with FTIR 
microscope (72 scans, R=2  cm−1, 5–25 repeats). Due to the practice 
of sampling huge amounts of plastics, no specific sample preparation 
is performed. The basis of the new method is the correlation between 
physico-chemical properties, molecular structure and patterns of vibra-
tion bands [2]. In data processing all spectra are baseline corrected 
and fitted with asymmetric Voigt functions to obtain all the vibration 
band areas. All areas of one spectrum are divided by each other, which 
leads to a highly characteristic dataset. Measurement statistics allows 
filtering these data to extract just analyte information and to separate 
matrix information. For characterization, these data are compared to 
references which are treated as well by multidimensional scaling com-
bined with a novel distance function and k-Means clustering.
By this method all measured samples could be classified accurately by 
their similarities and differences. Even small effects as those between 
HD- and LD-PE are identified correctly, which can be confirmed by ref-
erence literature [3]. The new method recognizes fundamental differ-
ences of synthetic and natural polymers and classifies even unknown 
synthetic and bio polyamides correctly.
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The cost of the reagents is one of the most important limiting fac-
tors in large-scale combinatorial library synthesis [1]. One task of the 
European Lead Factory Project (ELF) is to synthesize a new combina-
torial library of 200,000 compounds for high-throughput screening 
purposes [2]. In this presentation, commonly used reagent classes in 
ELF are analyzed with respect to their price and various properties like 
physicochemical descriptors, 2D-chemical diversity and 3D-likeness. 
The effect of different price cut-offs for building blocks to the combi-
natorial library design is illustrated using a library from ELF as a real-life 
example [3].
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Cheminformatics is becoming an essential asset in the chemist’s 
toolbox, especially when it comes to guiding experiments. How-
ever, the compendium of chemical biological datasets generated by 
experimentalists and available in publicly-accessible repositories is 
skyrocketing [1]. As a consequence, there is a general need for new 
cheminformatics technologies capable of handling, analyzing, and 
modeling Big Chemical Data [1]. In this presentation, we introduce 
three next-generation cheminformatics approaches that can:
(i) Enumerate extremely large virtual libraries: we will introduce the 
PKS Enumerator technology that generate millions of macrolides with 
user-defined building blocks and constraints. This research is relevant 
for the development of novel antibiotics.
(ii) Screen very large libraries of virtual compounds using a GPU-
accelerated platform: we will show how a GPU-powered ligand-based 
screening workflow can perform ultra-fast similarity searches among 
one billion molecules.
(iii) Use machine-learning techniques for analyzing molecular dynamics 
trajectories: we will discuss the rationale of examining both full-atom 
and coarse-grained molecular dynamics trajectories using machine-
learning techniques, what additional knowledge can be extracted, and 
how next-generation QSAR models could benefit of such technology.
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Plant products have always been the main source of medicine for 
man and several works on Nigerian medicinal plants used in treat-
ment of trypanosomiasis have been documented [1–3]. In this study, 
virtual screening was performed to evaluate the “drug-likeness” and 
ligand-receptor interaction of trypanocidal compounds isolated from 
Nigerian medicinal plants (Nijatryp). Lipinski’s “rule of five” (Ro5) was 
used to assess the relationship between structures and drug-likeness. 
About 94.62 % of Nijatryp compound dataset complied with Ro5 and 
demonstrated a significant enhancement in “drug-like” properties over 
Dictionary of Natural Product (DNP) dataset. About 31.18 % of plant 
metabolites in Nijatryp dataset have inhibition constant (Ki) in milli-
molar (mM) range and four compounds, we consider as hits, have Ki in 
micro-molar (µM) range. Results lay a foundation for a rationale devel-
opment of new leads from Nijatryp library.
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Reaction driven de novo design uses a library of reactions and a data-
base of reactants to perform a stochastic walk through “synthetic 
chemistry space.” Guided by appropriate drug design “scoring” such as 
docking or ligand shape similarity, such an approach provides a means 
to generate novel ideas for drug candidates that includes a proposed 
synthesis pathway. The methodology for reaction driven molecular 
evolution we have developed is independent of how the design ideas 
are scored. We will present studies where reaction driven de novo 
design software simulations are used to “re-invent” know drug mole-
cules or close analogs. When successful, the simulations also provide a 
proposed synthesis pathway to the compound under study. Examples 
which compare the “in silico” synthesis with the known synthetic path 
will be presented. This approach could also provide a novel means of 
suggesting synthesis schemes for synthetic chemists.
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Virtual screening based on high-throughput docking of millions of 
compounds is still not feasible due to required computational power 
and time. In a constrained based docking important protein-ligand 
interactions can be used to include additional knowledge and lead-
ing to a possible alternative for pharmacophore based pre-filtering of 
huge libraries. This was successfully shown by Koch et al. who identi-
fied the first inhibitors of an important protein-protein interaction in 
M. tuberculosis [1] based on a high-throughput constraint docking 
campaign using GOLD [2].
The underlying workflow contains several steps like constrained dock-
ing with very fast settings, pose filtering and redocking using exhaus-
tive settings. Up to now this processing steps had to be performed 
manually, since GOLD lacks a programming language API. Therefore, 
we developed a python wrapper for processing the gold configuration 
file and creating python-based automated virtual screening workflows. 
Using this wrapper an automated constrained docking workflow was 
implemented and used to analyze the performance of this approach in 
comparison to pharmacophore mapping-based virtual screening. First 
studies showed promising results on Poly [ADP-ribose] polymerase 1 
(PARP1), Janus Kinase 3 (JAK3) and Phosphoinositid-3-Kinase gamma 
(PI3Kg) from the DEKOIS2.0 dataset [3].
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The development of novel drugs is an arduous procedure which can 
take more than a decade and can accumulate expenses in the triple 
digit million euro range [1]. These facts remain true in spite of recent 
advances in virtual screening and computer-aided drug design [2]. 
The need for reasonably accurate and fast methods to predict and 
optimize the binding affinity which can drive the design process of 
drug-like molecules is therefore very high.
We here present novel methodology for computing binding free 
energies and their analytical dependence on chemical properties 
based on the so-called solute-solute equation of the reference inter-
action site model (RISM) [3]. This integral equation theory is derived 
from the molecular Ornstein-Zernicke equation and enables us to 
calculate the potential of mean force (PMF) including physics-based 
solvation contributions with very high computational efficiency. The 
PMF is the key quantity for characterizing chemical and biological 
processes since it represents the free energy change along a given 
reaction coordinate from which the binding free energy can be 
computed.
We derive the conceptual framework and demonstrate various appli-
cation areas of the model. PMF results from the solute-solute RISM 
approach are compared with explicit-solvent free energy perturbation 
molecular dynamics simulations in order to assess the approxima-
tions inherent to the theory for simple model systems. Optimal bind-
ing chemistry is defined by minimizing the free energy with respect 
to nonbonded complex interaction parameters. The results lead to 
suggestions for novel approaches to define protein-ligand scoring 
functions.
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The emerging understanding of selective modulation of Gamma 
Amino Butyric Acid (GABA) receptors allows an increase in the 
development of clinically efficacious and subtype selective drugs 
for these targets [1]. The development of various α-2/3 selective 
agonists is in process, for the treatment of anxiety disorders [2,3], 
however, the binding modes of these selective modulators is still 
unknown. In our study, we propose a unified pipeline of chemo 
genomic analyses of GABA modulators and established a link 
between their bioactivity, efficacy and mode of action on α-1 and 
α-2 receptors. We applied this protocol on a dataset of 5,440 GABA 
modulators and extracted a subset of compounds with desired 
structure activity relationship (SAR) and structure efficacy relation-
ship (SER). The similar behavior of candidate compounds in struc-
ture and activity space and their opposite behavior in functional 
efficacy space was assessed by assay related target similarity (ARTS) 
method. The dynamical behavior of GABA α-1/2 in the presence of 
selected compounds was analyzed using molecular dynamics simu-
lations to further elucidate the binding modes. The results obtained 
showed that sequence differences (G200E, I201T, V202I) in the loop 
C region of GABA α-2 subunit are likely to be responsible for desta-
bilizing the active site and hence decreasing the rigidity in presence 
of modulators as compared to α-1. To summarize, the behavior of 
the active site in presence of different modulators suggests that the 
difference in binding conformation of compounds could be attrib-
uted to structural differences in either the protein subunits or the 
compounds, and hence could possibly be a reason for their selective 
functional efficacy profiles.
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Here we demonstrate a new tool Metadyn View for visualisation of 
results of metadynamics [1] simulation technique. Metadynamics 
enhances sampling of classical molecular dynamics simulation by use 
of a bias potential. This bias potential can be used to predict the free 
energy surfaces of the studied system, i.e. equilibria and kinetics of key 
conformational changes, binding events etc.
Metadyn view [2] is a web-based program for exploration and analysis 
of free energy surfaces calculated by metadynamics. A user can load 
the results from metadynamics (a HILLS file), visualise the free energy 
at different stages of simulation, measure free energy differences 
and locate representative snapshot for free energy minima. It can be 
accessed on-line at http://metadyn.vscht.cz.
Applications of this tool to new simulations will be presented.
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In silico Mechanism-of-Action (MoA) analysis protocols have been 
developed in recent years, comprising molecule bioactivity profil-
ing, annotation of predicted targets with pathways and calculation 
of enrichment factors to highlight targets and pathways likely to be 
implicated in the studied phenotype [1,2]. Although such analyses 
report that pathway annotation improves the MoA information gained 
than by target prediction alone, these experiments are conducted on 
small and inconsistent datasets (approximately 1,500 compounds[1]).
In this work, we have combined an in silico target prediction tool, uti-
lising over 9.5 million and 600 million active and inactive datapoints 
respectively, with automated pathways annotation from the NCBI 
BioSystems database. This MoA protocol has been applied to over 
6,800 cytotoxic and 300,000 non-cytotoxic compounds from Astra-
Zeneca cell viability screens in order to rationalise the cytotoxic MoA. 
Post-processing of predictions involved the removal of targets with cor-
related activity due to overlapping bioactive compound annotations. 
Many of the enriched targets support known mechanisms of cytotoxic-
ity, with multiple pathways clustering around processes responsible for 
the fidelity of cell cycle, cellular division and metabolism.
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Fingerprints, a bit representation of compound chemical structure, have 
been widely used in cheminformatics for many years. The conversion of 
chemical structures into the bit strings is based on either structural keys 
or graph representations. Despite the fact that fingerprints with the high-
est resolution display high performance in virtual screening campaigns 
[1], the presence of a relatively high number of irrelevant bits introduces 
noise and makes their application more time-consuming.
Here, we present a new method of hybrid reduced fingerprints con-
struction—the MIC algorithm. The methodology was applied for 
fingerprints implemented in the PaDEL-Descriptor software [2]. The 
MIC algorithm was applied for ligands of cognate serotonin recep-
tors (5-HT2AR, 5-HT2BR, 5-HT2CR, 5-HT5AR and 5-HT6R). In the study, 
the length and composition of fingerprint is optimized separately for 
every single receptor by an algorithm which iteratively maximizes the 
amount of information included. Generated fingerprints applied in ran-
dom forest experiment outperformed every raw (original) fingerprint. 
Moreover, a universal fingerprint for the whole set of receptors was also 
developed and applied in machine learning experiments carried out on 
5-HT1A receptor ligands, which gave satisfactory results. The composi-
tion of hybrid fingerprints highlights the most important structural fea-
tures of the serotonin receptors’ ligands in machine learning evaluation.
Acknowledgement: This study was partially supported by the 
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The pharmacokinetic profile is paramount for the successful development 
of a new drug, and pharmacokinetics issues have a big impact on late 
stage attrition [1]. The ABC transporters’ efflux is one of the main factors 
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controlling the pharmacokinetics of a drug, hence being heavily studied. 
Here, we present two decision tree-based, multi-label QSAR models able 
to simultaneously predict substrates and non-substrates in a total of 1493 
compounds for 4 of the main ABC transporters [2] (BCRP1, MDR1, MRP1 
and MRP2). Each of these transporters corresponds to a binary class vari-
able, taking the value (class label) “substrate” or “non-substrate”, and the 
simultaneous prediction of the four class variables is performed by a multi-
label classification model, unlike the conventional (single-label) classifica-
tion task where just one class variable is predicted. One of the models—a 
Classifier Chain - was built to consider transporter (class) interaction, and a 
Binary Relevance model was used as the baseline model. Training, optimi-
zation and testing were performed with separate portions of the dataset. 
Feature selection was optimized from 5 different methods where the best 
method chosen for each transporter. Both models were validated with 
testing against y-randomization. The applicability domain was character-
ized using the STD method [3], and activity cliffs and chemical space cov-
erage were determined. Both multi-label models yielded 70% accuracy 
in the test set, but considering label interaction lead to more balanced 
models. The AD was able to reliably map the predictive accuracies across 
the dataset, which means that predictive reliability of new queries can be 
correctly determined. Moreover, various mispredictions coincided with 
activity cliff areas, which means that they could not have been picked up 
as outliers by any model using similar molecular descriptors. This multi-
label classification approach is an appropriate alternative for addressing 
the prediction of ABC efflux, especially considering the unspecific nature 
of substrate recognition by the ABC family members.
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The pharmaceutical and health industry makes continuous efforts to 
improve and increase the available variety of pharmaceutical treat-
ments. Medicinal chemists start the innovation cycle by systematic 
searches in all available published information, i.e. scientific journals, 
chemical databases and internal documentations.
A challenge is the existence of two separate information repositories: 
full text information and chemical structures/reactions contained 
in databases. This talk will describe how InfoChem has developed 
a technological infrastructure within the MarkLogic platform that 
allows effective and integrated searches in both full-text and chemical 
information.
Our talk will describe the underlying technologies developed in the 
ongoing project and present results of combined full-text and struc-
ture/reaction searches.
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Since available crystal structures usually only cover a small portion of 
possible protein conformations, drug development processes based 
on them can only detect a limited number of all possible ligands. 
However, ligand-based approaches often cover a broader range 
of binding conformations, but only a small part of possible bind-
ing site space at the protein, which is a reason to prefer structure 
based methods. Additionally, proteins with very similar binding site 
in available crystal structures can still adapt other conformations of 
high probability which enable the design of selective ligands.
In order to close this gap in ligand design a new method for binding 
site shape clustering was developed based on the test case PTP1B/TC-
PTP. PTP1B is a long known validated target for type 2 diabetes and 
obesity, while inhibition of the closely related TC-PTP leads to intoler-
able side effects in mice [1].
To collect protein conformations, molecular dynamics simulations were 
performed. Since for TC-PTP no crystal structure with required start-
ing conformation was available, a homology model was used instead. 
The collected molecular dynamics frames were aligned and for each 
frame the binding site was filled with a grid of points using the soft-
ware POVME2 [2]. The binding site shape information derived from the 
grids was translated into a matrix containing binary data for presence 
or absence of each point inside the binding site of the corresponding 
frame. Different clustering algorithms were then used to extract the 
present information on binding site shape differences. This way, bind-
ing site shapes with high probability in PTP1B, but low probability in 
TC-PTP can be discovered and the evidence can be used to select 
favourable shapes and interaction points for selective PTP1B inhibitors.
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Molecular docking is a one of the key tools in computer-aided drug 
design that is mainly used in virtual screening of compound libraries 
and to study mechanism of ligand-target interaction. However, a prob-
lem of effective scoring and discrimination between active and inac-
tive compounds is still not completely solved [1].
In this study, a novel protocol for the automatic evaluation of docking 
results is presented. In the first stage, the known active and inactive 
compounds are docked to receptor binding site; then the molecular 
interactions from the resulting ligand-protein complexes are encoded 
into binary format by means of the SIFt algorithm [2]. In parallel, 
conformations of docked ligands are used to calculate 3D molecular 
descriptors (PaDEL software [3]), and further concatenated with SIFt 
vectors. The obtained hybrid fingerprints are used as an input for the 
selected machine learning methods (e.g. SVM, RF, J48, Naïve Bayes) 
implemented in WEKA software [4].
Evaluation using compounds active toward 5-HT6, 5-HT7 and 5-HT1B 
receptors, proved that the methodology can be successfully used for 
supporting virtual screening protocols.
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For a broader recognition of halogen bonding in molecular design, we 
have recently studied halogen bonding contacts with different inter-
action partners in protein binding sites [1–4]. One of our goals was to 
examine the accessibility of the sulfur atom in the amino acid methio-
nine through halogen bonding [1]. We found in the c-Jun N-terminal 
kinases 3 (JNK3) an interesting target. In the binding pocket of JNK3 the 
sulfur of methionine 146 (MET146) appears to be targetable by halogen 
bonding (PDB 2p33) [5]. Herein, a chlorine atom shows very favourable 
distance (336 pm) and σ–hole angle (160.4°) to the sulfur of methio-
nine. In panel a) of the picture below, spherical interaction energies of 
iodine toward sulfur are plotted onto MET146. Favourable interaction 
geometries are highlighted by red colouring. The placement and bond 
direction of chlorine in the depicted ligand suggests a reasonable good 
quality of halogen bond (yellow area). DFT-calculations of a meaningful 
part of the binding pocket (TPSS-D/SVP) indicated that an exchange of 
chlorine by bromine and iodine could be useful for the strength of the 
halogen bond (b+c). Individual synthetic access was developed for the 
heavier halide analogues, which were then characterized by various bio-
physical techniques (d+e). By showing the crystal structure of the iodine 
analogue in complex with JNK3, we have obtained very valuable insights 
into the possibility and limitations of the application of halogen bonding 
in molecular design, which will be communicated in this talk [6].
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It is widely accepted that the human ATP binding cassette transport-
ers P-glycoprotein (P-gp, MDR1, ABCB1) and breast cancer resist-
ance protein (BCRP, ABCG2) are working in concert in order to restrict 
brain penetration of certain drugs. Known substrates and inhibitors 
of these transporters are showing a great structural variety, however, 
there exists some overlap in compound selectivity between the two. 
Because dual inhibition of P-gp/BCRP would lead to better oral bio-
availability and CNS penetration of i.e. anticancer drugs, information 
on determinants for specific or dual inhibition would be of great value 
in early phases of drug discovery.
However, the collection of pharmacological data for a target of inter-
est is a tedious task, especially if data from open data sources (like 
Open PHACTS or ChEMBL) is combined with literature data. If there 
are multiple targets involved, then the work becomes even harder.
We tackled this research question by creating a KNIME [1] workflow 
for conveniently combining data from the Open PHACTS Discovery 
Platform [2] and other data sources, including pre-processing, fil-
tering, annotation (e.g. creating a binary representation of the bio-
activities), and visualization steps. In our use case, P-gp and BCRP 
inhibition data was collected and their compound overlap was 
determined. Different ways of solving multi-label problems were 
explored and compared: label-powerset, binary relevance and clas-
sifiers chain. Label-powerset revealed important molecular features 
for selective or polyspecific inhibitory activity, while binary relevance 
and classifiers chain allow for more predictive models. The models 
reveal important molecular features for specific or polyspecific inhib-
itory activity such as SlogP, the number of donors and acceptors of 
H bonds, the number of aromatic atoms and the length of the maxi-
mum single bond chain.
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Understanding the underlying processes upon ligand binding is a key 
parameter in drug design. The early view of a lock-and-key principle 
has evolved to a more dynamic view of protein-ligand interactions. 
This requires an accurate treatment of both, the ligand and the protein 
dynamics. Up to now, there are still no robust methods to describe the 
complex interplay between ligands and proteins in an efficient manner 
and often these methods are limited to highly specialized hardware.
Recently, a novel Monte Carlo based algorithm combined with side 
chain prediction was introduced which efficiently explores protein-
ligand and protein-protein dynamics [1]. This Protein Energy Land-
scape Exploration (PELE) method has provided efficient and accurate 
induced fit results in respect to ligand migration and ligand binding 
events [2–4]. Originally, the protein backbone motion is limited to nor-
mal modes obtained by the anisotropic network model (ANM), a pure 
theoretical approach based on a distance matrix. Experimental param-
eters are not directly incorporated in these simulation, despite the fact 
that experimental data derived from X-Ray or NMR contain valuable 
information regarding conformational space and protein dynamics.
To make use of public or in-house available experimental information, 
we incorporated driving modes based on X-Ray structures. Testing the 
new approach using the mineralocorticoid receptor system showed 
an improvement of the general performance and the description of 
the protein motion. Currently, we are implementing NMR chemical 
shift information into PELE which guides the protein motion following 
experimentally observed chemical shifts. Overall, this will allow for effi-
cient sampling of ligand-protein binding events under direct consid-
eration of experimental data.
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We have made a comprehensive analysis of all IC50 and EC50 values 
with existing target gene id from the internal AstraZeneca screening 
and test database IBIS. The data was analyzed to arrive at statistically 
well-founded estimates for intra laboratory assay reproducibility. We 
find that the typical experimental precision is higher than commonly 
assumed with typical standard deviations between 0.21 and 0.26 log 
units. Interestingly the experimental uncertainty is relatively inde-
pendent of the test technology target-class and the functional read-
out (e.g. IC50 or EC50). Further we do not observe strong correlations 
of variability with common physico-chemical properties like logD or 
solubility. We also provide some explicit examples of ways to deal with 
uncertainty in data [1,2].
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Molecular docking is the most widely used method in modern com-
puter-aided drug design, regardless of being used in virtual screen 
or lead optimization. Molecular docking predicts the preferred ori-
entation of one molecule (ligand) to a bigger molecule (protein) to 
form a stable complex. The most complex and important step in this 
docking process is scoring. In this process, a large number of bind-
ing poses are computationally generated and then evaluated using 
a scoring function (SF), which is a mathematical or predictive model 
that produces a score representing binding stability of the pose. 
Generally, three main aspects of a SF define its goodness, they are 
“docking power”, “ranking power” and “scoring power” [1]. Report-
edly, conventional SFs are able to predict binding modes while 
mostly failed to predict binding affinities. In literature, SFs are typi-
cally classified as force-field-based, empirical, and knowledge-based. 
A first application of machine learning using Random Forest to pre-
dict binding affinities shows an increasing of more than 20% in term 
of Pearson’s correlation coefficient in a generic benchmark set with 
195 protein-ligand complexes [2]. Since then, a new class of SF has 
been intensively studied, the machine learning-based SF. Using CASF 
databases [3], we evaluate 11 novel conventional SFs (e.g. goldscore, 
DrugScore) and 10 machine learning-based SFs, we could show that 
scoring and ranking power of machine learning-based SFs are supe-
rior in comparison to conventional SFs. Especially ensemble learning 
classifier like Rotation Forest, in combination with diverse modifica-
tions by our own to guarantee diversity and accuracy, achieves the 
best performance in all cases.
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While the majority of life on earth is adapted to ambient pressure con-
ditions, on aver-age about 88% of the oceanic water on earth is 3800 
m deep, corresponding to a hydrostatic pressure of 380 bar, which is 
by far not the highest value on earth [1]. Bio-chemical processes for 
the vast number of lifeforms accommodated to these extreme condi-
tions are barely understood.
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Applying high solvent pressure to biomolecules has substantial 
impact on their free energy surfaces that govern structure, function 
and dynamics. This poses a challenge to computational modeling 
approaches since the applicability of conventional empirical force 
fields is not known. As a step toward clarifying the situation, we need 
to ac-count for high pressure in quantum-chemical calculations.
A suitable methodology is provided by integral equation theories, in 
particular the “embedded cluster reference interaction site model” 
(EC-RISM) [2,3] that combines statistical-mechanical 3D RISM integral 
equation theory and quantum-chemical calculations self-consistently. 
In this context the impact of pressure is naturally accounted for since 
the solvent susceptibility function that enters the theory contains 
the pure solvent correlation functions at the pressure chosen. Here 
we illustrate the methodology for several benchmark applications in 
a pressure range of 1 bar up to 10 kbar, including the effect of pres-
sure on molecular structure, the relevance of electronic polarizability 
un-der extreme conditions, and the pressure dependence of nuclear 
magnetic resonance parameters.
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DACS (Database of Available Chemical Compounds) is a virtual com-
pound collection of chemical substances prepared for analysis of the 
chemical space at the FMP. The database contains compounds offered 
since 2005 by more than 50 different vendors. Up to now we collected 
altogether 375 million data records, which were extracted from nearly 
3000 files. These data records represent more than 80 million unique 
chemical structures.
In July 2015, the beta release of open-dacs.de combined with an active 
web-interface is available for users. This release contains more than 
19 million unique structures. In the next release we are planning to 
include the 3D representations of the unique compounds in comple-
mentary to the 2D-structures to facilitate the direct application for vir-
tual screening and docking studies.
Furthermore, a first standard set of descriptors, such as number of 
H-bond donors/acceptors (NHBA/D), psa, alogp and divers solubility 
models [1–3] is available for filtering the search results. All chemical 
structures are tagged according to their content of reactive substruc-
tures following a list of SMART based rules, which are developed in the 
context of several library design initiatives [4, 5].
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The ever growing production of digital data as basis for scientific 
research has led funding agencies to regard data preservation and 
reuse as transparency-enhancing and cost-effective policies. On the 
other hand, scientific communities have early recognized the advan-
tage in the up-scaling and reuse of scientific data, and some subject-
specific repositories have emerged within the respective research 
fields, while interdisciplinary ones [1–3] still remain scarce.
RADAR (Research Data Repository) [4,5] aims to provide a significant 
contribution to the above described scenario, and to establish itself as 
discipline-agnostic, sustainable, and cost-transparent infrastructure, guar-
anteeing long-term digital preservation and thereby enhancing the reuse 
of research data. An additional and key aim of the project is to serve as 
a platform to support the peer-review of scientific articles, in which the 
underlying primary data is jointly submitted with the written manuscript.
Specifically, our project offers two distinct services: I) a preservation 
service, in which datasets are digitally preserved, and kept externally 
inaccessible, and II) a publication service, in which datasets receive a 
DOI and are accessible, free of costs, through our site [4,5]. The imple-
mentation of an OAI-PMH standard and an open API, for the har-
vesting of metadata and (published) datasets, respectively, is under 
development.
RADAR is a DFG-funded (2013–2016) initiative, consisting of an inter-
disciplinary team formed by the FIZ Karlsruhe, TIB Hannover, KIT/SCC, 
LMU Munich and the IPB Halle. We actively seek cooperation and feed-
back, not only from publishers and manuscript submission systems, 
but especially from the scientific community.
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The performance of chemoinformatic classification models is usually 
characterised by the prediction error (PE), which is estimated with an 
independent, external test data set. While the PE of the independ-
ent test set quantifies the overall model performance, rating the reli-
ability of an individual prediction is of importance in decision making. 
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To this end class probability estimates can be used. Generally, many 
supervised learning algorithms output some sort of probability esti-
mate, but they need not be well calibrated. However, when assessing 
the reliability of a prediction well calibrated probabilities are definitely 
needed. Logistic regression is most commonly applied for calibrating 
class probability estimates and was originally used to calibrate support 
vector machine (SVM) outputs [1, 2].
In this study, logistic regression was employed to calibrate the outputs 
of six classification techniques (random forest (RF), k-nearest neigh-
bour (KNN), SVM, partial least squares discriminant analysis (PLSDA), 
linear discriminant analysis (LDA) and naïve Bayes classifier (NBC). In 
addition to that, six regression techniques (random forest regression 
(RFR), support vector regression (SVR), sparse partial least squares 
(SPLS), lasso, elastic net and ridge regression) were also used to esti-
mate class probabilities. The quality of the calibration is assessed with 
reliability diagrams [3]. In detail, the mean squared error of prediction 
(MSE) for predicted and actual class membership probabilities are 
computed to quantify the degree of improvement. Furthermore, the 
influence of accuracy, correlation structure of the predictor matrix, 
and dataset size on the quality of class probability estimation was ana-
lysed in several simulation studies as well as with real data sets. From 
these studies, the following conclusions can be drawn: 1) within the 
accuracy range of 0.70 to 0.95, the probability estimates are reliable; 
2) accuracy and correlation have the largest influence on the quality 
of class probability estimation; 3) The data set size has minor influence.
With calibrated class probability estimates, it is straightforward to 
define the applicability domain by setting a threshold for the class 
membership probability below which the prediction of an object is 
rejected. Calibration is advantageous in this context to assure that the 
threshold coincides with the nominal probability.
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While Traditional Chinese Medicine (TCM) has been of great impor-
tance consistently throughout the years in China, there is still some 
more scientific rationale needs to be proven for it to be accepted 
further in the West. Given the increasing data of TCM chemical ingre-
dients and the availability of large-scale bioactivity data, we are now 
in the position to provide computational hypotheses for the mode-
of-actions (MOAs) of some TCM treatments, and to discover the rela-
tionship between the treatments. By using in silico target prediction 
algorithms, we generated a hierarchical clustering of 45 TCM thera-
peutic action (sub-)classes based on predicted bioactivity spaces, 
which were further annotated with KEGG pathways. The in silico tar-
get prediction of 10,079 TCM compounds showed a diverse bioactivity 
space, predicting a total of 409 unique targets and 171 unique path-
ways and 183 enriched targets and 99 enriched pathways based on 
Estimation Score ≤ 0 and ≥5% of compounds/targets in a (sub)-class. 
The TCM (sub-)classes were compiled into 14 clusters and the MOAs of 
each (sub)-class was established by associating the top three enriched 
targets/pathways to its indications with supporting literature. Overall, 
the most frequent top three enriched targets were immune-related 
targets such as tyrosine-protein phosphatase non-receptor type 2 
(PTPN2) and protein-kinase C family while the most frequent enriched 
pathway was related to digestive system such as mineral absorption 
and bile secretion. For instance, compounds from “Hemostatic, stasis 
resolving” showed wound healing activity, which can be suggested 
from the action of compounds against PTPN2 [1,2] and the mineral 
absorption pathway [3]. The annotation of the protein family showed 
that the G-protein coupled receptor (GPCR) and protein kinase family 
were mainly contributed to the diversity of the bioactivity space and 
pathway mapping indicated that the digestive system was consistently 
annotated, which agreed with the important treatment’s thought of 
TCM, “the foundation of acquired constitution” that includes spleen 
and stomach. This global overview enables the observation of similari-
ties and the differences between (sub-)classes, which are not apparent 
from the names given. Hence, this analysis hopefully helps to bridge 
the gap between TCM and Western medicine a bit further.
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Bacterial Macrophage Infectivity Potentiator (MIP) proteins and human 
FK506-binding proteins (FKBPs) both belong to the class of peptidyl-
prolyl-isomerases and exhibit a highly conserved binding pocket. 
The MIP protein of Burkholderia pseudomallei is important for replica-
tion and full virulence, rendering it a potential target for antimicrobial 
substances. Human FKBPs play miscellaneous roles, as for example in 
the regulation of steroid hormone receptor function and the immune 
response.
Several small-molecule pipecolic acid derivatives are capable of bind-
ing to MIP of B. pseudomallei [1], human FKBP and other MIP proteins, 
for example from Legionella pneumophila [2]. Analysing and compar-
ing the structure-activity relationships for these complexes is crucial 
for the development of new MIP inhibitors with sufficient selectivity.
In this study, differences in binding affinity between these proteins 
were investigated using docking studies and molecular dynam-
ics simulations. These analyses and the subsequent optimisation of 
the ligands are challenging owing to the narrow affinity range of the 
inhibitors and the shallow binding sites. A docking protocol was set up 
and validated by redocking to 24 crystal structures of FKBPs and MIP 
proteins of different organisms. Several directions for in-silico design of 
molecules exhibiting augmented selectivity are shown. Furthermore, 
a scoring-function-based binomial logistic regression model for pre-
diction of B. pseudomallei MIP inhibitors with submicromolar affinity is 
presented.
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The BioMAP systems are high-quality phenotypic screening assays 
and part of EPA’s ToxCast effort to prioritise chemical testing. Based 
on a robust metric, the nScore, 370 compounds were grouped into 82 
clusters. These clusters are the results of common underlying mode-
of-action and 4 out of the 82 clusters were identified with specific 
molecular targets using a novel target prediction algorithm. Indeed, 
only these four clusters were composed of compounds which all had 
at least one shared target in common. Moreover, these four clusters 
are equally identified when using two different metrics as activity cut-
off, further confirming their selective mode-of-action as compared 
to other clusters. Different activities were found for these four clus-
ters. The first and third clusters seemed to be associated with tar-
gets involved in nuclear receptor transcription, and are composed of 
compounds associated with cardiovascular toxicity biomarkers. How-
ever the third cluster is composed of compounds targeting proteins 
belonging to the family of retinoic acid receptors which additionally 
target lipid metabolism and adipocyte differentiation, while the first 
cluster is slightly more diverse and have compounds associated with 
fibrosis and restenosis biomarkers in addition of the cardiovascular 
inflammation biomarkers. The second cluster seemed to be associ-
ated with one specific target, the Sphingosine 1-phosphate receptor 
2, involved in G alpha signalling events and lysosphingolipid activity, 
and compounds belonging to this cluster do not seem to be associ-
ated with specific biomarkers. The last cluster is associated with 7 
targets active mostly in steroid hormone bio-synthesis, and with car-
diovascular and fibrosis biomarkers. The utility of this approach lies in 
the fact that compounds having the same target profile may be asso-
ciated with one of these clusters to better understand their mode-of-
action. As an example, 16 compounds were associated with one of the 
4 clusters, based on their predicted targets. For 3 of the 4 clusters, the 
biomarker profiles of the newly associated compounds were similar to 
those already in the cluster confirming the relevance of this approach. 
This approach may enable a comprehensive understanding of com-
pound in terms of mechanism-of-action, associated pathways and 
phenotypic profile.
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Generating quality 2D layout coordinates of structures from connec-
tion tables is a surprisingly difficult problem. Even if the general con-
nectivity of a compound is mapped to a visually pleasing layout, this 
is not sufficient to result in a compound rendering which is immedi-
ately recognizable to the eye of the pattern-trained chemist. There are 
many implicit conventions in the layout of chemical structures, con-
cerning standard orientations of ring systems as well as the placement 
of hetero atom within this ring and substituents on it or the selection 
of bonds with wedges to indicate stereochemistry. Textbooks gener-
ally agree on the layout of basic compounds, while most 2D chemical 
layout software has no notion about these. The consequence is, for 
example, that one can find in online databases drawings of pyridine 
(a trivial layout case where a simple polygon ring drawing algorithm is 
sufficient) with the nitrogen in all six possible positions, while we were 
unable to find any textbook where it was not on the bottom.
The Cactvs toolkit is the layout and rendering engine behind the 
PubChem database. Since more than a decade, the software has been 
one of the few engines which have been using advanced layout rules 
implementing implicit conventions in addition to computing a rea-
sonable 2D graph. This rule set has been significantly expanded, and 
includes improvements implemented in response to feedback of 
PubChem users and developers, as well as 3rd party vendors which 
have licensed the engine. We discuss details and examples of these 
developments.
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Within a few short years, the KNIME [1] dataflow environment has 
become an indispensable tool in chemical data analysis. The basic 
software already ships with a reasonable collection of chemistry 
nodes. It also enjoys the support of many vendors which provide a rich 
set if additional nodes covering most standard data processing needs 
for typical chemistry studies.
However, it frequently happens that there are minor gaps in the capa-
bilities of the turnkey nodes. The development of custom nodes within 
KNIME is possible, but requires an intimate knowledge of its software 
architecture and Java. A tool which would allow the specification of 
custom chemistry-aware nodes on a high level, for example by encap-
sulating scripts of a chemical information processing toolkit, would be 
a welcome addition. While scripting nodes exist in the KNIME collec-
tion, they either lack chemistry awareness, or are very limited in which 
actions they can perform.
We have now developed a KNIME node compiler for the Cactvs Chem-
informatics Toolkit as a new toolkit module. It directly generates a 
complete KNIME plugin-in Jar file from a very terse and high-level 
node description and a custom script. This script can perform any 
operation the toolkit in its stand-alone form is capable of. The new 
feature is a significant addition to the capabilities of the toolkit. Exam-
ples are shown and the unique development process for these custom 
nodes outside of the KNIME software proper is explained.
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Tuberculosis, caused by Mycobacterium tuberculosis, is one of the 
world’s deadliest infectious diseases affecting nine million people 
worldwide [1]. Due to emerging resistance against currently available 
antituberculotic drugs [2], novel potent inhibitors are urgently needed. 
M. tuberculosis thioredoxin reductase (MtTrxR) present a promising 
drug target since it plays a crucial role in antioxidative defense, prolif-
eration, and growth of M. tuberculosis, based on thioredoxin-depend-
ent reduction of target proteins e.g. ribonucleotide reductase with 
downstream effects on DNA synthesis [3, 4].
In a previous high-throughput docking approach, promising small 
molecule inhibitors of MtTrxR were identified that target the thiore-
doxin binding site [5]. In order to improve inhibition activity, extend 
the structure-activity relationship, and validate selected initial hits as 
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real hits, we performed virtual screening campaigns for these scaffold 
classes.
We will present the results of this in-silico analysis and the biochemical 
testing.
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The histone deaceylases SIRT4, and SIRT5 are mitochondrial proteins 
and are considered as metabolic sensors of cell’s energetic status. The 
two enzymes have important role in several human diseases such as 
cancer, and diabetes. SIRT4 regulates the glutamate dehydrogenase 
activity and insulin secretion, SIRT4 also functions as a cellular lipoami-
dase that regulates the pyruvate dehydrogenase (PDH), Its catalytic 
efficiency for lipoyl and biotinyl lysine modifications is superior to its 
deacetylation activity [1–3] whereas SIRT5 removes post-translational 
modifications such as lysine malonylation and succinylation [4]. Recent 
studies reported that SIRT4 seems to have a tumor-suppressive function 
[5,6] and may serve as a novel therapeutic target in colorectal cancer [7]. 
SIRT5 regulates urea production, reactive oxygen species (ROS) metabo-
lism, via regulating the carbamoyl phosphate synthetase (CPS1) [3].
Due to the absence of a crystal structure for human SIRT4, a homol-
ogy model was generated using different templates and computa-
tional approaches. The template selection identified human SIRT5 as 
most suitable template. MD simulations were carried out on the SIRT4 
models in complex with the cofactor and different substrates using 
program AMBER 12 to understand the stability and conformational 
changes of the modeled proteins in holo and apo form. In addition, 
several MD simulations of available crystal structures of SIRT5 in com-
plex and in apo form have been performed and compared with the 
results obtained for SIRT4. In addition, shape-based virtual screening 
for inhibitors and activators have been carried out.
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The quality and predictivity of most QSAR models used in drug design 
and development often depend on the particular tautomeric and 
valence structures used to represent the molecules of interest. This is 
because the location of hydrogens, bond orders, and formal charges 
affect the values of atomic and molecular descriptors upon which the 
models are based. For descriptors such as partial charges, this depend-
ence is typically due to basing atom typing on hybridization: e.g., sp3-
hybridized oxygen in -OH is treated differently than its sp2-hybridized 
counterpart in the =O group. That same oxygen may well occur in 
both forms in different tautomers of the same molecule. In the aque-
ous environment of interest in drug design applications, representing 
a compound as any one of its tautomers is likely to distort QSAR mod-
els trained using that tautomer. Even worse is the danger of choosing 
a tautomer present at low abundance, which will bias the model-
building process or the reliability of predictions or both. We have 
developed a descriptor generation method which is independent of 
tautomer and valence structure representation to address this prob-
lem and will illustrate its application to the atomic descriptors used 
in S+pKa, which is our global model of protic ionization constants. 
Preliminary results will be shown and compared with the “traditional” 
approach along with a discussion of advantages and potential pitfalls 
of the method. For example, “traditional” pKa predictions for amitrole 
produced five different sets of results depending on input tautomer 
(10.73, 3.56; 11.16, 4.84; 12.84, 9.94, 5.53; 11.31, 4.37; 14.79, 11.42, 7.47) 
whereas the new method yielded unique results (9.41, 4.02) regardless 
of the input tautomer.
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Despite recent advancements in biological and medicinal chemistry 
research, the numbers of new approved drugs are decreasing. There 
are more than 3000 potential drug targets surfaced as an outcome of 
Genomics revolution [1] and nearly 1033 compounds are estimated as 
drug-like chemical space [2]. Profiling interactions of these entities are 
much needed to purpose or repurpose chemical substances towards 
therapeutic targets. Since experimental ways to profile these chemical 
substances are costly, time-consuming and impossible on such large 
scale, computational prediction becomes an impending complement 
that offers valuable information in an efficient way. Amongst many 
available approaches, proteochemometrics (PCM) is distinctly benefi-
cial in exploiting ever-increasing drug-target interaction data [3]. PCM 
is an extrapolation of classical Quantitative structure–activity relation-
ship (QSAR), which were trained only on chemical data for particular 
target. On the other hand, PCM models are trained on both biologi-
cal and chemical data for multiple targets by various machine learning 
techniques.
In this work, a systematic approach based on PCM is reported (Fig. 5), 
which can predict interaction profile of given chemical moiety against 
therapeutic targets. Total 3036 interactions of 1473 proteins extracted 
from sc-PDB database are used for training the models [4]. This study 
also compares set of machine-learning algorithms (Random Forest 
and Support Vector Machine) and protein descriptors (Structure-
based and Sequence-based) for the proposed task. Best results were 
obtained by Random Forest model trained on Structure-based protein 
descriptors with the accuracy of 99% and 86% for test and external 
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validation set respectively. Outcome of the study suggest that pro-
posed models could be used to not only elucidate the intricate mecha-
nism of action of small molecules by identifying novel therapeutic 
target but also provide an opportunity to reposition existing drugs for 
new therapeutic application.
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iScienceSearch (http://isciencesearch.com/iss) is a free of charge 
application to search over 100 databases on the Internet, by struc-
ture, substructure, similarity, text and synonyms. If you type a name, 
we generate in the background automatically the chemical structure, 
the CAS Registry Number, other identifiers like AKOS number, and dif-
ferent names, if possible. We call this extended search. This means if 
you type Tamiflu, you also get answers that are perfectly correct, and 
where only the word Oseltamivir appears. Oseltamivir is a synonym 
for Tamiflu. You cannot search Google by chemical structure, and Sci-
Finder is not an Internet search engine. iScienceSearch is the system 
of choice searching the Internet for chemists and anybody who needs 
chemical information.
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Small chemical companies or suppliers of chemicals you would like to 
have a chemical information systems. However, you need to overcome 
a number of problems.
  • You have limited know-how about chemoinformatics
  • S ystems are expensive, especially if you want to equip everybody 
in your company
 • Systems are difficult to maintain
We offer you a solution that is based on Open Access software (Fig. 6).
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The global regulator Carbon catabolite Protein A (CcpA) controls car-
bon metabolism in Bacillus subtilis. It does so by binding to the degen-
erate consensus site WTGNNARCGNWWWCAW [1]. To investigate how 
CcpA can bind to such diverse sequence motifs, we tried to identify 
contributions to binding selectivity. On the one hand, direct contacts 
via hydrogen bonds and nonpolar interactions to the nucleotide bases 
(‘base readout’) strongly influence the preference of proteins for spe-
cific sequences. On the other hand, the base composition also influ-
ences the shape and flexibility of the DNA, thereby modulating the 
strength of the interactions.
The strongest conserved bases of the consensus site are the central CG 
bases, at which the DNA is bent in the complex structure. The direct 
Fig. 5 Schematic overview of the proteochemometrics based 
approach
Fig. 6 Screenshot of the Windows client
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contacts of the bases cannot explain the selectivity in respect to cen-
tral GC bases. In addition, CG represents a pyrimidine-purine base 
step, which is known to facilitate kinks, which might favour shape 
readout at this site.
To dissect the individual contributions of base and shape readout, 
the CcpA-DNA complex was simulated as wild type and compared to 
a mutant, in which the central CG base step was replaced by GC. The 
CcpA-DNA hydrogen bonds remained stable throughout the simula-
tion of the mutant, whereas the comparison of different MMPBSA 
analysis protocols showed a higher energy requirement to bend the 
mutant DNA sequence.
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It has long been the holy grail of computational structure-based 
ligand design to accurately predict binding free energies for novel 
compounds. This task is of special importance in fragment-based drug 
design, where typically multiple rounds of potency improvement are 
necessary to generate highly active lead structures out of micromolar 
initial inhibitors.
Molecular Dynamics based free energy calculations (or FEP for free 
energy perturbation) are among the most suitable methods to reach 
this goal, which would significantly impact the modern drug design 
process. Many of the issues previously encountered with FEP have 
been mitigated by our introduction of the FEP+ (free energy perturba-
tion plus REST, i.e. replica-exchange with solute tempering) methodol-
ogy along with state-of-the-art modern force field, together with the 
computational power offered by GPU computing.
The lack of large scale validation studies on diverse series of ligands 
are another obstacle for the practical application of FEP, due to the 
lack of computational resources and the time consuming process of 
simulation setup and analysis. Recently, we have conducted a valida-
tion study of FEP results on more than 10 targets and more than 500 
compounds, offering an order of magnitude more data than typi-
cal FEP studies and allowing statistically valid conclusion about their 
efficacy.
Here, we extend this validation study to fragment hit series binding a 
variety of pharmaceutically relevant target systems. Results for seven 
diverse protein systems with about 100 ligands are presented. Rela-
tive binding free energies can be calculated with good accuracy, typi-
cally with R-squared values in the range of 0.5–0.8 and mean unsigned 
errors (MUE) of about 1 kcal/mol when comparing to experimental 
data. FEP+ significantly outperforms alternative methods to deter-
mine binding free energies. This suggests that FEP+ binding energy 
predictions offer unsurpassed accuracy for fragments and lead precur-
sors as well as for drug-like molecules and could become a regular part 
of FBDD projects.
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The target-based identification and optimization of new drug leads 
heavily relies on computational techniques. Among these, virtual dock-
ing is a common method for investigation and evaluation of interac-
tions between small molecules and their receptors. Crucial questions 
for any docking study are: How well do the docking results agree with 
experimental data? Do the observed complexes occur in reality and is 
there a relationship between the docking score and the binding affin-
ity of a compound? It is common knowledge that the performance of 
docking procedures is generally target dependent. However, there may 
be many other factors that limit the predictive capabilities of docking.
In our research, we utilize docking for drug discovery against 
neglected tropical diseases like Human African Trypanosomiasis and 
leishmaniasis, which present a threat to millions of people world 
wide, who suffer from the limited number of currently available treat-
ment options. One enzyme involved in the parasitic folate metabo-
lism, pteridine reductase 1 (PTR1) is unique to the parasites, which 
makes it a promising target for anti-parasitic compound design.
We investigated different sets of chemically diverse PTR1 inhibitors 
with a small set of receptor template structures, but varying other 
aspects like docking methodology, protonation states and presence 
of structural waters. Our results show some key aspects for the choice 
of the method and pinpoint pitfalls in the selection of a receptor tem-
plate. As such effects are likely to impact other targets as well, the 
study should aid future target-based drug design efforts by highlight-
ing important considerations beyond the selection of a receptor tem-
plate for docking studies.
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P47  
SMARTSminer: Interactively mining discriminative patterns
Stefan Bietz, Karen T. Schomburg, Matthias Hilbig, Matthias Rarey
Center for Bioinformatics, University of Hamburg, Hamburg, Germany
Correspondence: Matthias Rarey ‑ rarey@zbh.uni‑hamburg.de 
Journal of Cheminformatics 2016, 8(Suppl 1):P47
Discriminative chemical patterns are used to distinguish molecules 
with different effects. Classifying the inhibiting, activating or toxi-
cological potential of an unknown molecule constitutes a central 
aspect in cheminformatics. The structural features of a molecule 
responsible for a certain effect can be represented with a chemical 
pattern. A chemical pattern is a substructure of the molecule, gen-
eralized or specialized with molecular features and logic operators. 
The SMARTS language [1] is the most frequently used representation 
for chemical patterns. While SMARTS strings constitute a powerful 
concept for the representation and processing of abstract chemical 
patterns, their manual generation remains a complex and time-con-
suming process.
Here, we introduce SMARTSminer [2], a new algorithm for the auto-
matic derivation of discriminative SMARTS patterns from preclassified 
molecule sets. Based on a specially adapted subgraph mining algo-
rithm, SMARTSminer identifies structural features that are frequent in 
only one of the given molecule classes. In comparison to elemental 
substructures, it also supports the consideration of general and spe-
cific SMARTS features. Furthermore, SMARTSminer is integrated into 
an interactive pattern editor named SMARTSeditor [3]. This allows for 
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an intuitive visualization on the basis of the SMARTSviewer [4] concept 
as well as interactive adaption and further improvement of the gener-
ated patterns. Additionally, a new molecular matching feature provides 
an immediate feedback on a pattern’s matching behavior across the 
molecule sets. SMARTSminer’s functionality and its integration into the 
SMARTSeditor software is shown in different classification scenarios.
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For structure based approaches a reliable structural model of the tar-
get protein, ideally bound with one or more effectors, is an essential 
requirement.
Besides internal industrial databases, a primary resource for such mod-
els is represented by the World Wide Protein Data Bank (wwPDB) [1], 
or PDB for short. Its repositories contain more than 113000 biological 
macromolecular structures of various qualities (as of August 2015). 
Most of these structures referring to a resolution below 3 Å. This num-
ber is a critical threshold for an appropriate refinement and structural 
meaningful optimization, to achieve the best possible fit between 
observed experimental structure factors (e.g. electron densities) and 
the chosen target function.
However, more than 7000 structures listed in the PDB were deposited 
with a resolution worse than 3 Å. The use of these structural models 
is questionable for structure-based approaches. Such low resolution 
structures are also often lacking the information of essential interac-
tions between the effector molecule and the target protein because of 
unresolved side chains.
For such purposes we hereby present an extended refinement strat-
egy to increase the structural information content of a crystal structure 
model. As an example a crystal structure of the Vascular Endothe-
lial Groth Factor Receptor 3 (VEGFR-3) with its ligand VEGF-C is used 
for further in silico modelling and binding studies. The resolution 
of this structure is 4.2 Å and lacks the information about crystallo-
graphic water molecules. Therefore a solvent analysis with 3D-RISM 
was applied to the complex. A combined standard crystallographic 
model-building of PHENIX and the structure modelling methodology 
of Rosetta was used, that utilizes an all-atom force field [2]. We will 
demonstrate the impact of a semi-empirical, linear-scaling, quantum-
mechanic method on the PHENIX refinement process [3]. The combi-
nation of all 3 different approaches was optimized to a workflow that 
produces a reliable structural model, useful for a meaningful analysis 
of ligand–receptor interactions, not seen in the original model. We 
believe such a workflow could be routinely established and may be 
important for several drug discovery programs.
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We present the complement of small molecule decoys on the side of 
protein binding pockets. The underlying concept of decoys is that they 
match the physico-chemical properties of their respective reference, 
while being structurally distinct [1]. Using Cavbase [2], a resource for 
abstract descriptions of protein binding pockets by so-called “pseu-
docenters“, protein decoy pockets are selected for any given reference 
binding site. We consider the types and number of pseudocenters as 
descriptor for the physico-chemical properties of a binding pocket. 
Accordingly, these descriptors should match between reference and 
decoy pocket. The recently developed RAPMAD approach [3] is used 
to select the most diverse pockets from those with matching physico-
chemical properties to ensure structural dissimilarity. RAPMAD is a 
comparison method for Cavbase pockets, which is sufficiently fast for 
database-wide screening approaches.
Protein decoy pockets can be applied in contexts comparable to those 
for ligand decoys, i.e. to assess docking performance in inverse dock-
ing setups or to test new ligand decoy sets. Another particularly inter-
esting application is the use of protein decoys in virtual screening to 
rescale docking scores. Docking scores corrected by these means can 
reduce the number of false positive hits as it has been described for 
ligand decoys [4].
Details on the decoy pocket selection method and results will be pre-
sented at the conference.
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Molecular environment of a biomolecule can affect its structure and 
function to different extents. We aim to study such influences for the 
following systems:
1. Human Islet amyloid polypeptide (hIAPP) is a 37-residue peptide 
which forms amyloid deposits associated with type-II diabetes mel-
litus. It is still unclear what triggers the conversion of soluble mono-
meric hIAPP into insoluble amyloid fibrils. We used replica exchange 
molecular dynamics (REMD) to sample the conformational space of 
the hIAPP dimer in explicit water, thus our work provides insights into 
the structural properties relevant to amyloid formation.
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2. Huntington’s disease (HD) is associated with the expansion of poly-
glutamine (polyQ) stretch of the huntingtin (htt) protein. Above a 
threshold of 37 glutamines huntingtin exon 1 starts to aggregate in a 
nucleation dependent manner. A 17-residue N-terminal fragment of 
exon 1 (N17) was shown to play a crucial role in modulating aggrega-
tion propensity and toxicity of htt exon 1. We used molecular dynam-
ics simulations to show that binding of CLR01 induces structural 
rearrangements within the N17 region of htt exon 1 monomer that 
leads to change in aggregation pathway of htt.
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Sleeping Sickness, Leishmaniasis and Malaria, infections transmit-
ted by protozoan parasites, are responsible for a great number of 
deaths and disease burden in tropical countries. New treatments are 
an urgent need. In this work combined correlative modelling (PLS) 
linking plant metabolite profiles and antiprotozoal activity with che-
mosystematic information, and in silico chromatographic retention 
time (tR) prediction to aid dereplication (the identification of known 
compounds) and the targeted isolation of known and new natural 
products with anti-protozoal activity. First, PLS correlative modeling 
(R 3.1.1 and The Unscrambler 9.2) was performed for UHPLC/ESI-QqTOF 
MS/MS data of extracts from Brazilian Asteraceae (n=140) and their in 
vitro activities against the protozoa Trypanosoma brucei rhodesiense, 
Leishmania donovani, and Plasmodium falciparum to select variables 
(metabolite data: m/z-tR) that were positively correlated with the 
activity. Secondly, the MS-data of these variables were related to the 
entries of an in house database containing the elemental formula 
and calc. m/z for 1360 natural products and taxonomic information 
on the plant species containing them. Hits for a particular elemental 
formula which were not reported as constituents of related plants 
(genus and tribus level) were excluded (chemosystematic filter). Then, 
3D structures of the remaining hits were generated and 3D descrip-
tors calculated (MOE 2011.10) and treated as previously reported [1]. 
An artificial neural network (ANN) model (Weka 3.6.6) as described in 
[1] was used to predict the hits’ retention time (tRp) in reverse phase 
HPLC-UV and to compare them with the experimental values (tRe). 
Selected compounds were isolated and structural elucidation was 
performed by means of MS and NMR. Several variables/compounds 
(n = 12) were positively correlated with the antiprotozoal activity. The 
initial number of possible structures related to an elemental formula 
(exact mass error: 20 ppm) queried in the database ranged from 5–70. 
Chemosystematic filtering reduced the number of possible structures 
to a range of 4–15. Comparison of tRe and tRp then greatly facilitated 
the identification of known compounds since only 1–2 possibilities 
remained. Seven of the compounds were isolated and all shown to 
be active against the protozoan parasites as suggested by the PLS 
correlation models. Three of them were new natural products. Over-
all, the combination of techniques proposed herein may complement 
MS-based dereplication, and can be successfully applied to streamline 
the discovery of new compounds with biological activity, such as an 
anti-protozoal potential, in crude extracts without time-consuming 
activity-guided fractionation.
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